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1.1 Metabolism in Escherichia coli 
 The major food sources for bacteria to live are carbohydrates, especially more 
common monosaccharides and disaccharides such as glucose, maltose and lactose.  
Depending on the availability of the substrates, specific genes that express proteins 
needed for uptake and consequent metabolism are encoded.  Therefore, if a particular 
substrate is not available, genes involved in the metabolism of that substrate are repressed 
[1].  In Escherichia coli, glucose and fructose are preferred carbon sources and other 
sugars such as maltose, lactose and arabinose are less preferred.  Therefore, if preferred 
carbon sources are available, proteins required for the metabolism of less favored carbon 
sources are not synthesized, which is known as carbon catabolite repression (CCR).  
After the availability of the favored carbon sources is exhausted, proteins needed for the 
transport and metabolism of more complex sugars are synthesized depending on their 
presence in the environment [1]. 
 
 
 The major role in bacterial CCR is performed by the phosphoenolpyruvate (PEP)
dependent sugar phosphotransferase system (PTS) 
conserving transport system, that uses PEP to phosphorylate carbohydrates during transport 
[1-2].  The energy required for the phosphorylation and the translocation of carbohydrates is 
generated by PEP [4].  Many sugars are transported by PTS, for example, glucose, fructose, 
and mannose, while other sugars, such as lactose, melibiose, and maltose 
former is called PTS sugars and the latter is called non
Figure 1-1.  The phosphoenolpyruvate
(PEP-PTS) for glucose.  PEP phosphorylates Enzyme I (EI) followed by the 
phosphoryl transfer to histidine
participates in the transport of all sugars.  The phosphoryl transfer to component A of 
Enzyme II (EIIA) occurs, subsequently, to component BC of EII (EIIBC).  The 
Enzyme II components are specific to individual s
being specific for glucose.  Phosphorylated EIIA activates adenylate cyclase while 
non-phosphorylated EIIA inhibits non
permease [3, 5].  
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Figure 1-1) [1-3].  The PTS is an energy 
are not 
-PTS sugars [5]. 
-dependent phosphotransferase system 
-containing phosphocarrier protein (HPr), which 
ugars with EIIAGlc and EIIBC
-PTS transport proteins such as the lactose 
-





 One of the essential molecules in PTS is Enzyme II (EII) consisting of at least three 
functional components: EIIA, EIIB, and EIIC.  EIIA is a separate subunit in E. coli but EIIB 
and EII C are linked.  Each component is specific for a particular sugar such as EIIAGlc for 
glucose.  EIIAGlc controls the synthesis of cyclic adenosine monophosphate (cAMP) and the 
activity of many membrane-bound transport systems [2].  The mechanism of catabolite 
repression is based on the level of cAMP, which is a product of adenylate cyclase that is 
regulated by EIIAGlc of the PEP-PTS system [6].  The concentration of cAMP is lowered if 
glucose is present [7].  More specifically, the phosphorylated EIIAGlc activates the adenylate 
cyclase, leading to the regulation of cAMP concentration in the cell, while non-
phosphorylated EIIAGlc hinders some proteins that are necessary in the metabolism of non-
PTS carbohydrates, such as the lactose permease and MalK, a protein which restricts the 
activity of the transcriptional activator for the maltose regulon (see section 1.3) [2, 4, 8]. 
 
1.2. Transcriptional Regulation in Bacteria 
 It takes only minutes for prokaryotes to respond to sudden environmental changes 
while eukaryotic cells need hours to days.  The reason for such a quick response to the 
environment is because transcription and translation are closely coupled in prokaryotes [7].  
The expression level of proteins depends on the physiological conditions of bacterial cells 
and the protein expression is controlled by the level of transcription [2].  The level of 
transcription is under the control of transcriptional regulation, which turn on and off the 




 An operon is a cluster of consecutive genes under the control of a single promoter (a 
site that precedes the transcribed portion of the gene) and an operator (a control site) (see 
Figure 1-2) [2, 9].  The operator acts as a regulator and controls the expression of the genes 
in the operon as a group.  The regulon, on the other hand, is a collection of genes or operons 
whose expression is controlled by the same regulatory protein or proteins [10].  The genes of 
the operon are located closely together whereas those of the regulon can be spread over the 
entire genome. 
 
 Unique regulatory sequences are present in the genome so that particular enzymes or 
regulatory proteins are able to bind and regulate the transcription of their target genes.  In 
prokaryotes, regulatory proteins such as activators and repressors bind to a specific site on 
the DNA molecule for the control of transcriptional initiation.  An activator protein binds to a 
specific control site to stimulate the initiation of transcription while a repressor protein binds 
to an operator or a promoter, leading to the prevention of the transcription initiation [9].  For 
instance, the CAP-cAMP (catabolite activator protein with cyclic adenosine monophosphate) 
complex stimulates the transcription of catabolite repressed operons and thus CAP is a 
positive regulator by initiating transcription [7].  Another example of a positive regulator is 
MalT, which is a transcriptional activator for the maltose regulon that binds to operator sites 
to control the expression of mal genes (see section 3.1).  The sites for positive regulators are 
found upstream of the promoter and the activity of the RNA polymerase is enhanced by 
binding of the activator, leading to transcription initiation [2]. 
 
 
 There are several well studied operons and one of them is the 
(Figure 1-2).  The lac operon consists of consecutive 
(galactoside permease), and A (thiogalactoside transacetylase), that encode proteins used in 
the metabolism of lactose.  The 
repressor that binds to the lac
the prevention of transcription of the structural genes (genes which specifically encode a 
polypeptide) [7, 9].  A small amount of lactose will be modified to allolactose if lactose is 
available, and it will bind to the repressor.  As a result, RNA polymerase is able to initiate the 
transcription of the structural genes (Z, Y, and A) 
food source for E. coli, the expression of more than 100 genes involved in the metabolism of 
other food sources such as lactose is prevented if enough glucose is available, which is the 
basis of the CCR.  Since the promoter of the 
transcription of structural genes is further stimulated when the CAP
the CAP-cAMP binding site of the 
(Figure 1-2) [7]. 
Figure 1-2.  The lac operon in 
sequence.  The I gene encodes the repressor that binds to the operator site, leading to 
the prevention of transcription of the 
lactose is available, an inducer generated from lactose binds to the repressor, thus 
5 
lac operon in 
g nes, Z (β-galactosidase), Y 
lacI gene, which is located in the lac operon, encodes the 
 promoter in the absence of allolactose (an inducer), leading to 
[9].  Since glucose is the most favorable 
lac operon is a CAP-dependent promoter, the 
-cAMP complex binds to 
lac operon in the absence of adequate amounts of glucose 
E. coli.  The open black box represents the DNA 






releasing it from the DNA, thereby RNA polymerase can bind to the promoter and 
transcribe the structural genes Z, Y, and A. [9]. 
 
 
1.3. The Maltose System 
 The maltose system is another notable example of transcriptional regulation in E. coli 
[2].  The maltose system is responsible for the catabolism of maltodextrins and glucose 
polymers containing up to 7 to 8 glucose units [6].  The maltose regulon is composed of five 
operons (malEFG, malK-lamB-malM, malPQ, malS, and malZ), and in E. coli there are ten 
mal genes that are regulated by MalT, the transcription regulator [6, 11].  There are many 
genes that affect maltose metabolism and regulation of mal gene expression and not all of 
them are part of the maltose regulon [6].  In this dissertation, the regulator MalT is the focus.  
The product of each gene of the maltose operon is a periplasmic, cytoplasmic or membrane 
protein.  The operons malEFG and malK-lamB encode the binding protein dependent ABC 
transporter, malP and malQ encode essential enzymes, and malS and malZ encode 
nonessential enzymes for maltose and maltodextrin metabolism [11].  malEFG nd malK-
lamB-malM rely on the binding of CAP-cAMP in addition to MalT while malPQ and malZ 
do not [6, 12].  However, the function of malM , another mal gene regulated by MalT, is still 
unclear [6].   
 
 MalT, which is a positive regulator, is the transcriptional activator for the mal genes 
and is encoded by malT [2, 6, 12-13].  Since the expression of malT is under the regulation of 
the CCR, it is controlled by the CAP-cAMP complex and repressed by Mlc (make large 
colonies), which is a regulatory protein of the PTS and curbs the utilization of glucose and is 
 
inactivated by EIIBGlc (Figure 1
is induced by maltotriose and ATP and repressed by MalK, MalY, and Aes (see section 3.1) 
[14].  MalY and Aes repress MalT by binding 
ATP binding site, and competing with maltotriose for MalT binding 
mechanism for these proteins to inhibit the MalT activity is similar but their binding sites are 
not identical, although they do seem to overlap 
 
Figure 1-3.  The regulation of the maltose system in 
of malT is activated (+) by CAP
by ATP and maltotriose and repressed by Aes, MalY, and MalK 
expression of some of the mal
and the CAP-cAMP complex
only depend on active MalT.
 
 The maltose system can be induced by other 
galactose, lactose, and trehalose.  Furthermore, maltotriose can be generated endogenously 
without maltodextrins [11].  It is suggested that there is a free internal unphosphorylated 
glucose generated in E. coli and 
biosynthesis, leading to the induction of the maltose system.  However, the origin of free 




-3) [2, 6, 11-12].  MalT is activated by multimerizing, which 
the N-terminus of MalT, which is also the 
[2].  It seems that the 
[15]. 
 
E. coli.  (A) The expression 
-cAMP and repressed (-) by Mlc.  MalT is activated 
[2, 16].  (B) The 
 genes is activated by the active form of MalT (active) 
, whereas the control of some of the other mal
 
sugars besides maltodextrins, such as 
it is involved in the pathway of endogenous maltotriose 




maltodextrin or non-maltodextrin is available to the cells and, thereby, mal genes are also 
induced with the degradation of galactose or lactose [11]. 
 
 There are still many functions that are unclear in the maltose system.  To better 
understand this remarkable E. coli metabolic system, the crystal structure of Aes, one of the 
down-regulators for MalT, has been determined in this study since the crystal structure 
determination of the protein gives insight into functions and assemblies of the protein.  










2.1.1 Literature Review for Aes 
 An acetyl esterase, also known as Aes from Escherichia coli, is a soluble protein 
consisting of 319 amino acids.  Aes, whose molecular weight is 36 kDa, is involved in 
catabolic carbohydrate metabolism [17-18].  Aes belongs to the hormone sensitive lipase 
(HSL) family [19-21] and hydrolyzes substrates whose acyl chain length is less than eight 
carbons, and an example reaction is shown in Figure 2-1.  Aes does not effectively 
hydrolyze large molecules such as trioleoyl glycerol and cholesterol oleate, thus showing 
no lipase activity [11, 19]. 
 
 
Figure 2-1.  Acetyl esterase activity of Aes.  The reaction above is carried out as the 
colormetric enzyme assay in order to know whether purified Aes is active.  Aes 
catalyzes the hydrolysis of p-nitrophenyl esters of fatty acids whose acyl chain length 




Besides the catalytic activity, Aes down regulates MalT, which is the transcriptional 
activator of the maltose regulon [15, 22-23] (see section 3.1).  Moreover, a recent study 
suggests that an interaction forms between Aes and α-galactosidase [24].  The E. coli α-
galactosidase catalyzes the hydrolysis of α-linked-galactosides such as those found in the 
more complex sugars raffinose and melibiose [25].  Since Aes interacts with several 
important proteins in E. coli, it should play critical roles in the control of carbohydrate 
metabolism. 
 
Aes is evolutionary related to the mammalian HSL, which is a member of the 
GDXG (X can be any amino acid) family, suggesting histidine or serine will be in the 
active site in either the residues 87 to 103 (LFYLHGGGFILGNLDTH) and/or 158 to 170 
(IGFAGDSAGAMLA) [32].  The Gly-X-Ser-X-Gly pattern is found to be the consensus 
sequence around the active serine of the HSL family and is also found in esterases, serine 
proteases and lipases.  Even though the GXSXG pattern is found in lipases, esterases and 
serine proteases, the tertiary structure of the serine proteases is different from the others 
and aspartate is sometimes substituted with glutamate to form the catalytic triad in some 
proteins [26-29].  Besides the GXSXG pattern, HGGG or HG for the lipolytic lipase 
(LPL) family (LPL, hepatic and pancreatic lipases) is also a conserved pattern in these: 
HSL, EST (carboxylesterases), and lipases families [20].   
 
 The enzymatic catalysis is necessary for living system and the active site 
(catalytic site) is the pocket where the enzyme-catalyzed reaction takes place.  The 
11 
 
substrate is bound to the active site, which encloses and sequesters it from the solution 
[10].  The catalytic triad, consisting of Ser, His, and Asp, is found in the active site of 
certain enzymes, such as proteases, and plays the critical role in the enzymatic activity.  
Therefore, the recognition of the active site of the enzyme will lead to a better 
understanding of the function of the enzyme.  According to recent studies, the catalytic 
triad of Aes is suggested to be Ser165, Asp262 and His292, and this triad is conserved in 
distantly related prokaryotes as well as in the mammalian hormone sensitive lipase (HSL) 
[20, 30]. 
 
 Aes is classified as a lipolytic enzyme (PROSITE: PDOC00903) [31-32] and 
there are different classes of lipolytic enzyme produced in bacteria: carboxylesterases, 
lipases and phospholipases.  Caryboxylesterases hydrolyze small esters and lipases 
hydrolyze the ester bond in long triglycerides.  The substrates of carboxylesterases are 
soluble while lipases act efficiently on the insoluble part of the substrate.  Such enzymes, 
which come from fungus or bacteria, are used in biotechnology as food ingredients, 
biocatalysts, and pitch control in the pulp and paper industry [30].  Therefore, a better 
understanding of such proteins will help in the discovery and development of novel 
enzymes used in these fields. 
 
2.1.2 Classification and HSL 
 Cholinesterases, carboxylesterases, esterases, and lipases are the members of the 
α/β hydrolase fold family that shares the similar structure of a central β-sheet surrounded 
12 
 
by α-helices.  This family is separated into three subfamilies, C-family, L-family and H-
family.  More specifically, acetylcholinesterases, cholesterolesterases, carboxylesterases, 
neuroactins and lipases from fungi belong to the C-family, lipases such as pancreatic 
lipase and lipoprotein lipase belong to the L-family, and hormone-sensitive lipase (HSL) 
and lipases from bacteria fit in the H-family [33].  HSL shows high relative activity at 
low temperature, below 15 °C, however, interestingly, the sequence similarity is observed 
in thermophilic (high temperature loving), mesophilic (moderate temperature loving) and 
psychrophilic (low temperature loving) organisms [34].  Therefore, temperature stability 
and activity preferences among them are not from the sequence conservation [30].  HSL 
is involved in many different metabolic processes and are present in heart, skeletal 
muscle, testes, and brown adipose tissue but not present in kidney and liver.  Since HSL 
plays a role in energy metabolism, it may be involved in diabetes and obesity.  HSL 
releases energy by hydrolyzing triacylglycerol, which is the major energy source for the 
heart, to glycerol and fatty acids under hormonal and neural control [35].  HSL is also in 
charge of hydrolysis of the neutral cholesterol ester in macrophages [36].  Therefore, it is 
possible that the accumulation of cholesterol ester in atherosclerosis would be reversed 
by the activation of HSL [35].  Moreover, cold adaptability could be controlled by HSL 
in poikilotherms whose body temperature varies with the environment and hibernators 
that depend on fat stores as their energy source during winter [37].  Therefore, it should 
be necessary for HSL to function at lower temperatures.  HSL is a unique enzyme whose 
activity is controlled by cAMP-dependent phosphorylation and its structure obtained 
from sequence information and modeling is not homologous to other lipases, suggesting a 
unique function [38].  Therefore, it is interesting to understand the structure and function 
13 
 
of HSL that is involved in the energy homeostasis [38-39].  Moreover, since Aes from E. 
coli is homologous to the catalytic domain of HSL even though the whole HSL structure 
may be different to Aes, the structure determination of Aes should lead to understanding 
the functional and evolutional relationship of proteins belonging to the H-family 
including HSL [19-20, 40]. 
 
 
2.2 Materials and Methods 
2.2.1 Genomic DNA Isolation from Escherichia coli 
 One Shot TOP10 Chemically Competent Escherichia coli cells (E. coli K12 
strain, Invitrogen) were used to isolate genomic DNA [41].  First, 5 mL Luria-Bertani 
(LB) liquid media with 50 µg/mL ampicillin (LB/Amp50) was inoculated with E. coli 
cells and incubated at 37 °C overnight with shaking (200 rpm, MaxQ 500 shaking 
incubator, Barnstead Lab-Line).  An aliquot (1.5 mL) of the culture was centrifuged 
(Marathon microcentrifuge, Fisher Scientific) in a microcentrifuge tube and the 
supernatant was discarded.  The pellet was then resuspended in 567 µL TE (50 mM Tris-
HCl pH 8.0 and 10 mM EDTA (ethylenediamine tetraacetic acid)) buffer by pipetting and 
30 µL of 10% SDS (sodium dodecyl sulfate) and 3.0 µL of 20 mg/mL proteinase K were 
added.  The solution was mixed well and incubated for 1 hour at 37 °C.  Sodium chloride 
(100 µL of 5 M) was added to the solution and mixed well, followed by the addition of 
80 µL of CTAB/NaCl solution (prepared by dissolving 4.1 g NaCl in 80 mL water and 
adding 10 g hexadecyltrimethyl ammonium bromide (CTAB) while heating at 65 °C, 
adjusting the final volume to 100 mL).  Afterwards, an equal volume of 24:1 
14 
 
chloroform/isoamyl alcohol was added, mixed thoroughly, and spun for 5 minutes in a 
microcentrifuge.  The aqueous supernatant was transferred to a fresh microcentrifuge 
tube, an equal volume of 25:24:1 phenol/chloroform/isoamyl alcohol was added to the 
supernatant and the mixture was spun in a microcentrifuge for 5 minutes.  The 
supernatant was transferred to a fresh microcentrifuge tube and 0.9 mL of isopropanol 
was added to the supernatant to precipitate the genomic DNA.  The mixture was shaken 
well and spun in a centrifuge to harvest the DNA.  The DNA was washed with 70% 
ethanol in water and centrifuged for 5 minutes to repellet.  The supernatant was removed 
carefully and the pellet was dried by blotting on a paper towel.  Afterwards, the pellet of 
DNA was redissolved in 100 µL TE buffer and stored at -4 °C. 
 
2.2.2 Polymerase Chain Reaction and Gel Extraction of PCR Product 
 The aes gene (aes) was amplified by polymerase chain reaction (PCR) using a 
PTC-150 Minicycler (MJ Research).  The forward primer 5’-
CACCATGAAGCCGGAAAACAA ACTAC-3’ and reverse primer 5’-
CTAAAGCTGAGCGGTAAAGAACTG-3’ were purchased from Invitrogen and these 
primers were diluted with sterile deionized water to 20 µM to be used in PCR.  To 
perform PCR, 5.0 µL of 10X AccuPrime PCR Buffer II (Invitrogen), 1.0 - 4.0 µL of both 
the forward and reverse primers (20 µM), 1.0 - 4.0 µL of DNA isolated from E. coli 
(section 2.2.1), and 1.0 µL AccuPrime Taq Polymerase (Invitrogen) and sterile distilled 
water to adjust the final volume to 50 µL, were mixed in sterile PCR tubes.  In the 1st 
cycle, the DNA was denatured for 6 minutes at 94 °C, annealed for 30 seconds at 55 °C, 
and extended for 1 minute at 68 °C.  From the 2nd to the 30th cycle, denaturation for 45 
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seconds at 94 °C, annealing for 30 seconds at 55 °C, and extension for 1 minute at 68 °C 
were performed.  As the final cycle, extension was done for 5 minutes at 68 °C (Table 2-
1). 
Table 2-1.  Program used in minicycler in order to amplify aes by PCR.  The 
minicycler was programmed in this way in order to amplify aes.
 1st Cycle 2nd -30th Cycle Final Cycle 
Denaturation 94 ˚C 6 min. 45 sec.  
Annealing 55 ˚C 30 sec. 30 sec.  
Extension 68 ˚C 1 min. 1 min. 5 min. 
 
Most of the 957 bp PCR product (40 µL) was mixed with 8.0 µL of loading buffer (30% 
glycerol, 20 mM EDTA, and 100 µg/mL crystal violet) and loaded onto a 1.0 % agarose 
gel (1.5 g agarose in 150 mL of TAE (Tris-acetate-EDTA: 40 mM Tris pH 7.6, 20 mM 
acetic acid, and 1 mM EDTA buffer)) with 750 µL of crystal violet solution (2 mg/mL) in 
deionized water for the detection of the PCR product.  The PCR product was verified 
through agarose gel electrophoresis (80 V for 3 hours, Sub-Cell GT agarose gel 
electrophoresis, BioRad). 
 
  The Invitrogen PureLink Quick Gel Extraction Kit was used in order to purify the 
PCR product from the agarose gel so that any impurities were removed from the PCR 
reaction mixture.  The bands containing the correct size of the PCR product were cut 
from the agarose gel with a sterile razor blade and up to 400 mg of gel were placed into 
1.5 mL microcentrifuge tubes.  The Gel Stabilization Buffer (GS1) was added to the tube 
with 30 µL for every 10 mg of the gel.  The tube was incubated for 15 minutes at 50 °C 
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with mixing every 3 minutes. After the gel slice was visibly dissolved, the tube was 
incubated for an additional 5 minutes to ensure the complete dissolution of the gel. 
 
The mixture was transferred into the Quick Gel Extraction Column that was placed onto 
the Wash Tube and spun for 1 minute in the microcentrifuge at the maximum speed.  The 
flow through was discarded, 500 µL of GS1 was added to the column, and the tube was 
incubated at room temperature (RT) for 1 minute.  The flow through was discarded and 
700 µL of Wash Buffer (W9) with 70% ethanol was added to the column, followed by 
incubation at RT for 5 minutes.  Afterwards, it was centrifuged for 1 minute and the flow 
through was discarded.  The tube was centrifuged for 1 more minute to ensure that any 
buffer was removed.  The column was placed onto the Recovery Tube and 50 µL of pre-
warmed Tris-HCl (10 mM, pH 8.0) was added to the center of the cartridge.  The tube 
was incubated at RT for 1 minute and centrifuged for 2 minutes at the maximum speed.  
The purified DNA was stored at -20 °C. 
 
 The agarose gel electrophoresis was performed to confirm the size of the purified 
PCR product in the same manner as written above except for using ethidium bromide (EB, 
0.5 µg/mL of agarose gel) for the detection of the DNA.  The DNA was visualized with 
UV light and the concentration of the purified PCR product was determined as 4-10 µg/ 
µL according to the DNA mass ladder (Invitrogen).  Afterwards, the purified PCR 




2.2.3 The TOPO Cloning Reaction and Transformation 
 The TOPO cloning reaction was performed using the ChampionTM pET 
Directional TOPO Expression Kits (Invitrogen) [42].  Reaction mixtures were prepared in 
sterile microcentrifuge tubes ((A), (B), and (C) in Table 2-2), followed by the incubation 
at RT for 5 minutes.  Two negative controls (tubes (A) and (B)) and one positive control 
(tube (D)) were performed in order to check the background of vector and PCR product, 
and the competency of the E. coli strain.   
Table 2-2.  Reaction mixtures set up for the TOPO cloning reaction.  (A) and (B) 
are negative controls to check the background of the PCR product and the vector, 
respectively.  (C) is the cloning reaction mixture.  (D) is the positive control using 
control pUC 19 that is a part of the TOPO expression kit.  Values are in µL. 
 (A) (B) (C) (D) 
Gel extracted PCR product 1.5 - 1.5 - 
Salt solution 1 1 1 - 
Sterile water 3.5 4 2.5 - 
TOPO vector - 1 1 - 
pUC 19 - - - 1 
Total volume 6 6 6 1 
  
 After the incubation, the tube was transferred onto ice and 3.0 µL of the reaction 
mixture was mixed into a vial of One Shot TOP10 Chemically Competent E. coli 
(Invitrogen) on ice without pipetting up and down.  For (D), pUC19 (1 µL) was added 
directly to a vial of competent cells on ice.  The vials were incubated on ice for 15 
minutes and then the bacterial cells were heat-shocked for 30 seconds at 42 °C in a water 
bath.  The vials were transferred back to the ice bath and 250 µL of room temperature 
S.O.C. medium was added to each of the vials.  The mixtures were then incubated 
horizontally at 37 °C with shaking at 200 rpm for 1 hour.  An aliquot (200 µL) of each of 
the transformation mixtures were spread using a sterile bent glass rod on pre-warmed (37 
18 
 
˚C) LB agar plates containing 100 µg/mL of ampicillin (LB/Amp100).  The plates were 
inverted and incubated overnight at 37 °C. 
 
2.2.4 Analysis of the Transformants 
 Well isolated colonies (about 10 colonies) were picked using sterile toothpicks 
from the LB/Amp100 agar plate and each colony was used to inoculate 10 mL of 
LB/Amp100 medium.  They were cultured for 12 hours at 37 °C shaking at 200 rpm.  For 
propagation and maintenance of the plasmid, 0.9 mL of the culture was mixed with 0.3 
mL of 60% sterile glycerol solution in a 2 mL cryo-vial and stored at -80 °C. 
 
 The cells were harvested with centrifugation at 4500 rpm for 5 minutes at 4 °C 
(Allegra X-15R Benchtop Centrifuge, Beckman Coulter) in order to isolate the plasmid 
from the cells with the use of the Wizard Plus SV Miniprep DNA Purification System 
(Promega) [43].  The supernatant was discarded and the tube was inverted onto a paper 
towel so that the supernatant was removed from the tube.  The pellet was resuspended in 
250 µL of the Cell Resuspension Solution (50 mM Tris-HCl pH 7.5, 10 mM EDTA, and 
100 g/mL RNase A) by vortexing.  The resuspended cells were transferred to a sterile 1.5 
mL microcentrifuge tube and mixed with 250 µL of the Cell Lysis Solution (0.2 M 
NaOH and 1% SDS) by inverting the tube 4 times.  The mixture was incubated at RT for 
4 minutes and 10 µL of Alkaline Protease Solution was added to the mixture, followed by 
inverting the tube 4 times.  The mixture was incubated at RT for 5 minutes.  This process 
inactivates the endonuclease and other proteins released during the lysis of bacterial cells.  
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A 350 µL volume of the Neutralization Solution (4.09 M guanidine hydrochloride, 0.759 
M potassium acetate, and 2.12 M glacial acetic acid) was then added to the mixture and 
immediately mixed by inverting the tube 4 times.  The lysate was spun at maximum 
speed with the Marathon Microcentrifuge (Fisher Scientific) for 20 minutes at RT.  The 
cleared lysate was then transferred to the Spin Column, which was inserted into a 2.0 mL 
Collection Tube.  It was centrifuged at maximum speed for 1 minute at RT.  The flow 
through was discarded from the tube and 750 µL of the Column Wash Solution (60 mM 
potassium acetate, 8.3 mM Tris-HCl, 60 % ethanol, and 0.04 mM EDTA) was added to 
the column.  The tube was spun for 1 minute at RT and the flow through was discarded.  
The column was washed with 250 µL of Column Wash Solution and spun for 2 minutes 
at RT.  The Spin Column was placed into a sterile microcentrifuge tube and the plasmid 
was eluted by the addition of 100 µL of Nuclease-Free water, followed by centrifugation 
for 2 minutes.  Afterwards, the isolated plasmid was stored at -20 °C. 
 
 To confirm the presence of the insert of the aes gene (aes), the plasmid was 
subjected to restriction enzyme digestion and the fragments (2 kbp and 4 kbp fragments 
were expected to be seen on the agarose gel if aesw s inserted) were run on a 1% 
agarose gel.  As shown in Table 2-3, 6.5 µL of the sterile deionized water, 8 µL of 
plasmid DNA (10 µg/µL), 4 µL of MultiCore Buffer (Promega), and 0.5 µL acetylated 
BSA (10 µg/µL) were mixed in sterile microcentrifuge tubes and centrifuged for 30 
seconds.  The restriction enzymes SacI, which cuts the vector at position 416, and 
EcoRV, which cuts the vector at 556 and 4167, (both are from Promega), were added to 
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the tubes gently by pipetting and the tubes were spun for 30 seconds.  The tubes were 
then incubated in a water bath at 37 °C for 2 hours [44].   
Table 2-3.  Restriction enzyme digestion.  The following components were mixed 
in sterile microcentrifuge tubes to verify the plasmids by use of restriction enzymes. 
Sterile deionized water 6.5 µL 
 10x restriction enzyme buffer (multicore) 4.0 µL 
Acetylated BSA (10 µg/ µL) 0.5 µL 
Plasmid DNA (ng/µL) 8.0 µL 
Sac I (10 units/µl) 0.5 µL 
Eco RV (10 units/µl) 0.5 µL 
Total volume 20.0 µL 
 
 A 1.0 % agarose gel was prepared in the same way as stated in section 2.2.2 using 
ethidium bromide as a DNA detection tool.  After the incubation of the plasmid with the 
restriction enzymes, the digested samples (5 µL) were electrophoresed at 80 V for 2 
hours.  The plasmids that were confirmed to carry the insert by the restriction enzyme 
analysis were further verified with DNA sequencing at the Recombinant DNA/Protein 
Resource Facility of the Biochemistry and Molecular Biology Department (Oklahoma 
State University).  The T7 promoter and terminator primers were used to verify the insert 
of aes into the pET100/D-TOPO vector with the correct size and orientation. 
 
2.2.5 Over-Expression of Aes 
 The recombinant plasmids were transformed into BL21 StarTM (DE3) One Shot 
cells (Invitrogen) which were designed for the expression of genes regulated by the T7 
promoter.  To transform the construct, 2 µL of the plasmid DNA (10-15 µg/µL) was 
added into the vial containing BL21 Star cells on ice and stirred gently with a pipette tip.  
21 
 
The vials were incubated on ice for 30 minutes and then heat-shocked for 30 seconds at 
42 °C in a water bath.  The vials were immediately transferred back onto the ice, 
followed by the addition of S.O.C. medium (250 µL, pre-warmed to RT).  Afterwards, 
the vials were incubated at 37 °C for 30 minutes with shaking at 200 rpm.  The 
transformation mixture (one vial per transformation) was added to 10 mL of LB/Amp100 
liquid medium (a seed culture) and grown overnight at 37 °C with shaking at 200 rpm. 
 
 Since each recombinant protein has different characteristics for its expression, a 
time course study of the expression of Aes was performed in order to investigate the best 
condition for the protein expression.  Two aliquots of seed culture (750 µL) were used to 
inoculate two tubes, each with 10 mL of LB/Amp100, one tube was for the induction of 
the protein and the other was not induced.  The bacteria were grown for about 2 hour at 
37 °C with shaking until an OD600 reached 0.6.  The cells in the first tube were induced 
for over-expression of the recombinant protein with 1 mM of isopropyl-β-D-1-
thiogalactopyranoside (IPTG, Sigma) and an aliquot (500 µL) from each tube was 
collected in a microcentrifuge tube and centrifuged for 30 seconds every hour, starting at 
the time of induction.  After discarding the supernatant, cell pellets were frozen at -20 °C 
for later sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
analysis.  The incubation of the remaining culture was continued at 37 °C for 6 hours. 
 
 To analyze the protein expression, pellets were thawed at RT and resuspended in 
80 µL of SDS-PAGE sample buffer by vortexing.  After incubation at 100 °C for 5 
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minutes, the microcentrifuge tubes were centrifuged briefly and 5-10 µL of sample from 
each tube was loaded onto a 15% SDS-PAGE gel, followed by electrophoresis at 200 V 
for about 30 minutes using a Mini-Protein 3 Cell electrophoresis apparatus (BioRad) 
[45].  The solubility of the protein was also studied by sonicating (Sonifier 150 Liquid 
Processor, Branson) the pellet from 4 mL LB culture, which was resuspended in 500 µL 
of ice-cold Buffer A (20 mM TrisHCl pH 7.9, 500 mM NaCl, and 20 mM imidazole), for 
30 seconds and 1 minute rest on the ice bath.  This process was repeated three times so 
that the majority of the cells could be disrupted completely.  The sample was centrifuged 
at 4 °C for 1 minute to pellet insoluble proteins. 
 
 The supernatant was transferred to a microcentrifuge tube and 500 µL of 2x SDS-
PAGE sample buffer was added to the tube, followed by boiling at 100 °C for 5 minutes.  
The pellet was resuspended with 450 µL of 1x SDS-PAGE sample buffer, boiled at 100 
°C for 5 minutes, and spun for 1 minute.  The samples from the supernatant (10 µL) and 
the pellet (5 µL) were loaded onto a 15% SDS-PAGE gel and electrophoresed.  Since 
Aes (confirmed by westernblotting) was found more in the pellet (insoluble phase) than 
in the supernatant (soluble phase), the optimal conditions for culturing to make Aes more 
soluble was investigated.  After trials, it was found that culturing should be carried out at 
30 °C after the induction and the addition of lysozyme allowed Aes to be more soluble. 
 
 Since a large amount of protein was necessary to obtain protein crystals, the 
expression of the protein was scaled-up.  To scale-up the expression, 200 mL of 
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LB/Amp100 was inoculated with 5 mL of the seed culture and incubated at 37 °C until the 
OD600 reached 0.6.  The over-expression of the Aes was induced by adding 1 mM IPTG 
and the temperature was lowered to 30 °C and cultured for 4 additional hours with 
shaking at 200 rpm.  After the time course of the large scale expression study, Aes was 
over-expressed and found mostly in the soluble phase.  Thus, cells were harvested by 
centrifugation at 4500 rpm, 4 °C and stored at -80 °C until needed. 
 
2.2.6 Purification of Aes 1: Ni Chelate Affinity Chromatography 
 The cell pellet from 400 mL culture was resuspended in 10 mL of Buffer A and 
0.005 g of lysozyme (Invitrogen) was added, followed by incubation with shaking (200 
rpm) at RT for 15 minutes.  The sample was then sonicated (initially Branson Sonifier 
150 and then XL-2000 series Ultrasonic Liquid processors) on an ice bath for 30 seconds 
and 1 minute rest three times.  The lysate was centrifuged at 4500 rpm for 15 minute in a 
sterile 50 mL falcon tube and then the supernatant was transferred to a 15 mL centrifuge 
tube.  The tube was centrifuged at 4500 rpm for a few hours until the supernatant became 
clear. 
 
 The Biologic Duo-Flow Chromatography System (BioRad) was used to purify 
Aes.  Since the recombinant Aes contained an N-terminal poly-histidine tag (His6-Aes), 
immobilized metal affinity chromatography was used for the purification [46].  The 
supernatant containing Aes was loaded onto the HisTrapTM HP Column (GE Healthcare) 
and Aes was eluted by a linear gradient with increasing imidazole concentration (1% 
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increase of imizadole concentration per minute).  During the purification process (flow 
rate 1.0 mL/min), the buffer blender was used to blend Buffer A1 (40 mM TrisHCl and 
1.0 M NaCl) and Buffer A2 (40 mM Tris and 1.0 M NaCl) so as to adjust the pH to 7.9.  
This was further blended with Buffer B1 (deionized water) and Buffer B2 (1.0 M 
imidazole).  The linear gradient for the imidazole concentration was created by adjusting 
the percentage of B2.  Fractions were collected and select fractions were used for a 15 % 
SDS-PAGE to verify the presence of Aes.  Since Aes was eluted with 240 mM imidazole, 
step wise purifications were performed for subsequent purifications, which eluted most of 
the impurities at 20 mM imidazole, more tightly bound impurities at 100 mM and Aes at 
500 mM imidazole. 
 
2.2.7 Purification of Aes 2: Desalting Column Purification 
 Since impurities were not observed in fractions containing Aes on the 15% SDS-
PAGE gel after the Ni chelate affinity chromatography, samples were loaded onto the 
desalting column (HiPrep 26/10 Desalting GE Healthcare) in order to remove excess 
amount of imidazole and to exchange the buffer from Tris to Buffer B (25 mM 
ammonium acetate pH 7.5, 150 mM NaCl, and 150 mM imidazole).  The fractions from 
the desalting column were analyzed with 15 % SDS-PAGE.  Matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometer (MALDI-TOF) at the recombinant 
DNA/Protein Resource Facility of the Biochemistry and Molecular Biology Department 
was used to confirm that Aes was present.  Because purified protein was confirmed as 
Aes, fractions were pooled and concentrated to 5 mg/mL with a 20 mL VIVA SPIN, 
10000 molecular weight cut-off (MWCO) (ViVa Science) by centrifugation at 1500 rpm 
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and 4 °C.  The concentration was determined by the Bradford protein assay using BIO-
RAD Quick Star Bradford Protein Assay Kit [47].  Moreover, the enzyme assay using p-
nitrophenyl butyrate was performed to see whether the purified Aes was active [19]. 
 
2.2.8 Crystallization 
 To determine the preliminary crystallization conditions for Aes, Crystal ScreenTM 
I and II (Hampton Research) were used in the hanging drop vapor diffusion method [48].  
The purified Aes sample in Buffer B (5 mg/mL, filtered with a 0.45 µm HT Tuffryn 
membrane filter) was used in the screening.  For Screen I and II, 24 well crystallization 
plates (Hampton Research) were used and 750 µL of each reagent was pipetted into the 
wells, which had the rim greased with high vacuum grease (DOW CORNING).  On a 
microscope cover slip (VWR), a droplet of 3.0 µL of Aes and 3.0 µL of the reservoir 
solution was prepared, and the microscope cover slip was inverted over the well and 
sealed with the grease.  Conditions were duplicated for RT and 4 °C.  For the Index 
Screen (Hampton Research), the sitting drop vapor diffusion method was carried out with 
a 96 well crystallization plate (Axygen).  A 150 µL aliquot of screen reagent was pipetted 
into the wells and 1.0 µL of Aes was mixed with 1.0 µL of the reservoir solution in a 
smaller well formed in the plate for sitting drop experiments.  Afterwards, the plate was 
sealed with clear non-reactive tape and stored at RT.  All plates were checked 
periodically for crystal growth.  In addition to these methods, a silica hydrogel (Hampton 
Research) sitting drop vapor diffusion method was performed since rapid nucleation for 




 Crystals were found in a few weeks to a month with the following conditions (see 
section 2.3.3): Index # 9, 12, 15, 44, 47, Screen I # 7, 20, and Screen II # 31.  Since 
crystals formed in Screen I # 7 (0.1 M sodium cacodylate trihydrate pH 6.5 and 1.4 M 
sodium acetate trihydrate) were single and relatively big, crystals were reproduced with a 
hanging drop vapor diffusion method with 1.0 mL freshly prepared reservoir solution and 
the crystallization condition was optimized to obtain well defined and high quality single 
crystals.  To optimize the crystallization conditions, the concentration of Aes, the pH of 
the buffer, and the concentration of each reagent were altered.  After optimization, 
crystals of the size 0.45 x 0.35 x 0.15 mm3 grew in a few weeks. 
 
2.2.9 Data Collection 
 Once good single crystals were formed, preliminary data collections were 
performed.  Before the data collection, single crystals were lassoed by a nylon loop (0.05 
to 0.5 mm diameter, Hampton Research) from the drop, dunked in oil (Paraton-N, 
Hampton Research), and then immediately mounted onto the goniometer head of the X-
ray diffractometer (Bruker Microstar) under a nitrogen cryo flow (100 K: Oxford 
Cryosystems COBRA).  The X-ray generator was set with the power at 2.5 kW (45 kV 
and 60 mA).  Once the crystal was mounted, it was aligned in the center of the X-ray 
beam.  To test whether diffraction occurs, various parameters were set as follows with the 
system software (Proteum2) [49].  The distance from the goniometer to the detector was 
set at 70 cm and exposure time was 120 seconds.  If no diffraction was observed on the 
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detection screen, the crystal was removed and other crystals would be mounted to test 
whether diffraction occurred.  If they diffracted, the unit cell was determined by 
Proteum2 and exposure time was extended to 300 seconds with the distance being set at 
120 cm for preliminary data collections [50].  More specifically, for the preliminary data 
collection, a data collection scheme was developed by Proteum2 to expose the crystal to 
the X-ray beam for several frames at different angles.  Each frame was collected for 300 
seconds followed by a 0.5 degree rotation of the crystal.  A total of 724 frames were 
collected.  To determine the structure of Aes, diffraction data were collected for about 24 
hours from a single crystal of His6-Aes at the wavelength 1.5418 Å. 
 
 After the data collection, raw data were processed with SAINT-NT and XPREP 
[51-52].  More specifically, raw crystallographic data frames were converted by SAINT-
NT into integrated intensity sets with error analysis, background subtraction, etc.  The 
processed data were then analyzed by XPREP so as to determine the space group and 
evaluate data statistically.  The number of molecules per asymmetric unit was also 
determined with Matthew’s coefficient (VM) using the following equation [53-54]:  
 
VM = V/ (n*M*X)  
 
where V is the volume of the unit cell, n is the number of asymmetric units in the unit cell, 
M is the molecular weight and X is the number of molecules in the asymmetric unit.  
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When VM falls within the range from 1.68 to 3.53 Å
3/Dalton, the value of X is considered 
to be most probable.  The Matthew’s coefficient also gives the expected solvent content 
(obtained by 1-1.23/VM) that should be in the range of 27 to 65%.  After the 
determination of the space group and the number of molecules per asymmetric unit, data 
were transferred to a Linux based workstation (OS: Ubuntu) in order to convert .hkl data 
to .mtz data that is hkl data in binary format used in CCP4 [55]. 
 
2.2.10 Molecular Replacement 
 In order to determine the initial phases for the data collected, molecular 
replacement was carried out with PHENIX [56-57] using the homologous proteins: acetyl 
esterase from Salmonella typhimurium (PDB code: 3GA7, 70% identity), hyper-
thermophilic carboxylesterase from Archaeon archaeoglobus (PDB code: 1JJI, 29 % 
identity) [58], carboxylesterase from a metagenomic library (PDB code: 2C7B, 27% 
identity) [59], thermophilic carboxylesterase EST2 from Alicyclobacillus acidocaldarius 
(PDB code: 1EVQ, 26% identity) [60], and mutant M211S/R215L of carboxylesterase 
EST2 complexed with hexadecanesulfonate (PDB code: 1QZ3, 26% identity) [57, 59-
63].  The percent identity for each homologous protein was obtained from RCSB PDB 
(Research Collaboratory for Structural Bioinformatics Protein Data Bank) [64].  Since 
initial phases were determined using a homologous protein, the acetyl esterase from 
Salmonella typhimurium (3GA7), the amino acid sequence was based on this sequence.  
Therefore, after phase determination, the amino acids were altered with the molecular 
modeling software COOT [65] so that it would possess the same sequence as Aes from E. 




 First, molecular replacement was performed as follows with dataset His6-Aes1, 
which was collected on a single crystal and refined in the rhombohedral R32 space group.  
The PDB file of 3GA7 was downloaded from the PDB and water molecules and a 
phosphate were removed from the file so that only the protein coordinates of 3GA7 were 
obtained.  On a Linux workstation (OS:Ubuntu), phenix.automr data.mtz (reflection data 
collected in this study) 3ga7.pdb rms=1.0 (pdb file of 3ga7), italicized letters being the 
syntax to start the program, was carried out on the terminal.  As a result, MR.1.pdb and 
MR.1.mtz were generated as protein coordinates and phased structure factors to generate 
the electron density map, respectively.  In order to know whether the molecular 
replacement worked for the initial phase determination, phenix.refine MR.1.pdb data.mtz 
were performed.  Since Rfree = 0.46663 dropped to Rfree = 0.4415 after the refinement, 
initial phase determination was considered successful and then further investigations 
were carried out as follows.  The mtz file was opened in COOT to check whether protein 
coordinates fit to the electron density map (rendered at σ = 1.0) and alternative 
conformations were removed from the protein coordinates (saved as start.pdb).  Then, 
phenix.refine start.pdb data.mtz was performed and Rfree = 0.4213 before refinement and 
Rfree = 0.4052 after the refinement were observed.  After the refinement, 
start_refine_002.def (show the result of refinement) was generated and then it was used 
in further refinement.  Some parameters were modified on start_refine_002.def as b-
factor = 20.0 and incorporated simulated annealing = True and then phenix.refine 
start_refine_002.def was performed.  After repeating these refinement steps, Rwork 
lowered but Rfree increased even though both R values should lower if molecular 
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replacement succeeded in phase determination.  Therefore, this phase determination was 
considered not good enough for further structure determination.  After trying the same 
procedures for another dataset, His6-Aes3 that was from a different crystal and also in the 
rhombohedral space group (possibly R3), the molecular replacement was not really 
successful. 
 
 The same procedure was then performed with the dataset His6-Aes2, which was 
from a single crystal that crystallized in the tetragonal P41 space group.  Since it showed 
better R values after refinements, protein coordinates generated from this data led to the 
structure determination of Aes.  According to the Matthew’s coefficient analysis and 
molecular replacement, six molecules were found in the asymmetric unit.  Therefore, 
after initial phase determination, relationships among these molecules were investigated 
with the molecular visualization program Rasmol in order to see the non-crystallographic 
symmetry [66].  According to the symmetry investigation, there were three dimers in the 
asymmetric unit in which chain A forms a dimer with chain E, chain C forms a dimer 
with chain F, and chain B forms a dimer with chain D. 
 
 Afterward, the model of Aes in P41 (His6-Aes2) was manually re-built with 
COOT by adjusting the amino acid coordinates of the model used in the molecular 
replacement to fit the electron density map obtained from the crystal data and the model 
phases [65].  At the early stage of this process, model building was performed on chain A 
and the same modification was applied to all other chains using “SSM superposed” on 
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COOT, which simply copied the modified chain A to the location of the other five 
molecules.  To achieve this, set reference structure = pdb file containing all chains and set 
moving structure = chain A.  Moreover, change chain ID from A to B so that the 
modification on chain A is applied to chain B.  Performing the same translation to the 
other chains, six molecules in the asymmetric unit have the same structure as chain A.  
Therefore, non-crystallographic symmetry (NCS) was applied while refining the model 
with PHENIX.   The model was alternatively refined with PHENIX (see section 2.2.11) 
and built manually with COOT until the agreement between the data and model 
converged, in other words, Rwork and Rfree had reached to less than 30% and no more 
improvement could be obtained [57, 67]. 
 
2.2.11 Refinements 
 After all the amino acids were altered to the ones corresponding to Aes from E. 
coli, further investigations for each amino acid in chain A were performed with COOT in 
order to obtain a better model of Aes.  Initially, side chains of amino acids in chain A 
were truncated into alanine if poor electron density was observed and the same changes 
were applied to other chains as mentioned in 2.2.10.  Moreover, since the electron density 
was missing around residues 26 to 35, these amino acids were removed at this point.  
Refinements, using PHENIX, were then performed with simulated annealing in order to 
obtain a better model that fit to the electron density map [68].  After each refinement, 
protein coordinates were observed in COOT to investigate whether the electron density 
map had improved so that the residues truncated to alanine could be altered to the proper 
amino acid.  Depending on the density obtained from the refinement, some amino acid 
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residues were altered or built to fit to the density map.  The same modifications were also 
performed on the other chains followed by refinement with PHENIX.   
 
 After several rounds of refinement, translation/libration/screw (TLS) [69-70] was 
applied in the refinement.  TLS parameterizes a model in a physically sensible form 
(group) that will be refined by translation, libration, and screw components [71].  
Initially, a TLS parameter file was prepared (tls_group_selections.params) where each 
chain was treated as a group.  Since there were 6 molecules in the asymmetric unit, chain 
A was firstly refined and then copies of chain A were produced to generate all 6 
molecules of the asymmetric unit along with simulated annealing and TLS to improve the 
model and electron density map. 
 
 At the beginning, the electron density of an N terminal loop (residues 26-36) was 
noisy and not contiguous as mentioned above.  However, after several rounds of 
refinement, part of this density appeared.  Therefore, a few amino acid residues were 
built step by step to complete the loop region around the N-terminus.  Since this loop 
region did not obey the NCS well with each chain showing a different conformation, this 
region was excluded from the NCS definition and the loop of each molecule was 
manually modeled based on the Ramachandran plot, torsion angle and geometry around 
each amino acid residue.  After the fifth round of refinement, water molecules were 
added automatically by PHENIX.  Moreover, investigations for some positive density 
around the plausible active site for Aes were performed to determine what types of small 
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molecules fit and were chemically and physically reasonable.  However, these were not 
successful.  Therefore, the model without water molecules or small molecules were 
retained and refined to determine the structure of Aes. 
 
 When almost all of the amino acid coordinates were built, Molprobity [72] was 
performed to validate the model (see Table 2-7).  According to the comprehensive 
validation, there were still a few residues that were out of the preferred region in the 
Ramachandran plot (see Table 2-8).  Thus, these residues were manually refined and also 
refined with TLS, and moderate NCS excluding residues that were unique among each 
chain. 
 
 Afterwards, using the model, TLS Motion Determination (TLSMD) was 
performed in order to analyze the flexibility of the protein crystal structure [73-74], 
leading to the generation of a new TLS parameter file that better represents the motion of 
the six molecules in the asymmetric unit of the crystal.  After trying several different TLS 
partitioning for each molecule, it worked better that chain A and F were partitioned into 5 
parts, chain B and C into 4, and chain D and E into 3.  Therefore, the TLS parameter file 
for PHENIX was generated in the TLSMD server with this partitioning and used in 
further refinements.  In addition to this new TLS parameter, rotamer and geometry 
validation were performed in COOT (see Table 2-9).  Based on rotamer validation and 
the Ramachandran plot, some residues that were unique and outliers were modified so 
that they obtained preferred rotamers and geometries and fell into the favored region on 
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the Ramachandran plot.  Moreover, these residues were excluded from NCS in 
refinement since they showed different orientations in the different chains.  After 
modifications to the rotamers and outliers, refinement with PHENIX was performed 
followed by validation using Molprobity.  These processes were repeated several times to 
improve the model.  Moreover, twining analysis was re-performed using updated 
software with phenix.xtriage [56-57].   
 
 Once the structure was determined, proteins with similar fold were found using 
the DaLi server [75] to find proteins that shared the fold with Aes.  Moreover, the 
multiple sequence alignment (MSA) was performed by ClustalW [76] so as to understand 
the relationship between the sequence similarity and structure, using the following 
homologous proteins: an acetyl esterase from Salmonella typhimurium (PDB ID: 3GA7), 
a hyper-thermophilic carboxylesterase from Archaeoglobus fulgidus (1JJI), a new 
thoermophilic and thermostable carboxylesterase cloned from a metagenomic library 
(2C7B), a thermophilic carboxylesterase Est2 from Alicyclobacillus acidocaldarius 
(1EVQ), a mutant M211S/R215L of a carboxylesterase Est2 complexed with 
hexadecanesulfonate (1QZ3), a hormone-sensitive lipase like Este5 from a metagenomic 
library (3FAK), 3DNM is a hormone-sensitive lipase from a metagenomic library, a 
brefeldin A esterase that is a bacterial homologue of human hormone-sensitive lipase 




2.3 Results and Discussion 
2.3.1 PCR 
 The set of reactions that were set up to lead to the production of the aes g ne in 
PCR is summarized in Table 2-4.  Initially, the reaction volume was 25 µL but it was not 
enough for sequencing and further research.  Therefore, 50 µL of reaction mixture was 
prepared for further research. 
 
Table 2-4.  Reactions that led to the production of aes.  (Volumes in µL). 
10X Accu Prime PCR Buffer II 2.5 2.5 2.5 2.5 2.5 
aes forward (20 µM) 0.5 1.5 1.0 2.0 0.5 
aes reverse (20 µM) 0.5 1.5 1.0 2.0 0.5 
DNA template 1.0 0.5 1.0 0.5 0.5 
Accu Prime Taq Polymerase 0.5 0.5 0.5 0.5 0.5 
Sterile Distilled Water 20.0 18.5 19.0 17.5 20.5 
Total Volume  25 25 25 25 25 
 
 Agarose gel electrophoresis was carried out to check the size of the PCR product 
that was purified from the agarose gel (Figure 2-2).  The size of the PCR product was 
found to be about the same size as the aes gene and the concentration of the purified PCR 
product was found to be about 10 ng/µL.  After the validation of the PCR product, 






Figure 2-2.  Size analysis of the PCR product by agarose gel electrophoresis.  1% 
agarose gel was stained with ethidium bromide.  Lane 1: density marker, lanes 2-6: 
PCR products extracted from the agarose gel, and lane 7: 100 bp size marker. 
 
2.3.2 Over-Expression and Purification of Aes 
The plasmids carrying the aes gene were constructed and verified by restriction 
enzyme analyses and DNA sequencing as described in Materials and Methods.  
According to sequencing, there were no mutations found in the recombinant aes.  After a 
series of investigations about the optimal condition for aes’s over-expression, it was 
found that aes needed to be incubated for 4 hours at 30 °C after induction by the addition 
of 1.0 mM IPTG.  At the beginning, Aes was found more in the insoluble phase after 
sonication but the solubility of Aes was improved with more Aes in the soluble fraction 
by lowering the temperature during culturing (Figure 2-3).  As a result, a large quantity of 
Aes was purified through Ni (II) chelate affinity chromatography (Figure 2-4). 
 








Figure 2-3.  SDS-PAGE gel analysis showing solubility and purity of Aes.  15% 
SDS-PAGE gel stained with Coomassie blue.  Lane 1: size marker (Precision Plus 
ProteinTM Standards, Bio-Rad), lane 2: crude extract from un-induced culture, lane 3: 
crude extract from induced culture, lane 4: sample from insoluble phase after 
sonication, lane 5: sample from soluble phase after sonication, lane 6: sample purified 
by Ni (II) chelate affinity column, and lane 7: sample purified with desalting column.   
 
 According to the chromatogram from Ni chelate affinity chromatography, Aes 
tightly bound to the column, being eluted with 500 mM imidazole.  The other bacterial 
proteins were eluted as either flow through or with 100 mM imidazole (Figure 2-4).  
Therefore, Aes obtained from the Ni affinity column was mostly pure as shown on a 15% 
SDS-PAGE gel (Figure 2-5).  The buffer was then exchanged with a desalting column so 
as to lower the salt concentration.  The chromatogram from the desalting column 
chromatography showed Aes was eluted faster than the salt since the size of the protein is 
larger (Figure 2-6).  There were no other bands observed on SDS-PAGE gel after 
purifications as shown in Figures 2-5 and 2-7.   








Figure 2-4.  Chromatogram generated by Bio-Rad DuoFlow as a result of Ni 
chelate affinity column purification of Aes.  The black line shows the percentage of 
500 mM imidazole used to elute the proteins, pink is pH of the solution, red is the 
conductivity and blue is the absorbance.  Impurities are mostly eluted at the beginning 
as flow through, indicated by the elevation of the blue line from test tube #3 to #13.  
Aes is eluted at 500 mM imidazole into test tube #33 to #35.  Samples labeled as #1 to 




Figure 2-5.  SDS-PAGE analysis of Aes purified by Ni chelate affinity column 
chromatography.  10% SDS-PAGE gel stained with Coomassie blue.  First lane from 
the left contains size marker and the numbers for each lane correspond to the sample 
number on the chromatogram.  Aes was eluted with 500 mM imidazole and the 
amount of impurities was negligible.  Samples # 6, 7 and 8 were pooled and used for 


















Figure 2-6.  Chromatogram generated by Bio-Rad DuoFlow as a result of 
desalting column purification of Aes.  Aes is eluted into test tubes #9 to #12.  




Figure 2-7.  SDS-PAGE analysis of Aes purified by desalting column 
chromatography.  10% SDS-PAGE gel stained with Coomassie blue.  First lane 
from the left contains size marker and the numbers correspond to the sample number 















According to the MALDI-TOF analysis (matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometer), purified protein was confirmed 
as carboxylesterase (ybaC, synonym of Aes) from E. coli K-12 strain (Figure 2-8) using 
molecular weight search (MOWSE) and Mascot as scoring and search engines [77-79].  
About 15 mg of Aes (the concentration of the final pooled sample was about 1.5 mg/mL), 
determined by Bradford Assay, was obtained from 400 mL bacterial culture after 
purification and Aes was concentrated to 5 mg/mL in buffer B to be used in 
crystallization.  Moreover, according to the enzyme assay, purified Aes was active. 
 
 
Figure 2-8. MALDI -TOF result of band after purification.  Proteins whose 
probability based MOWSE score is greater than 78 are considered as significant and 
the top score was 125, confirming it as probably carboxylesterase, ybaC (gene 
synonym of aes), from E. coli (strain K-12).  
 
2.3.3 Crystallization 
 Crystal screening was performed by the hanging drop vapor diffusion method to 
investigate crystallization conditions of Aes using Crystal Screen kits from Hampton 




Table 2-5.  Crystallization conditions that led to the formation of crystalline 
material or small crystals for Aes.  
Protein Name Preliminary Crystallization Condition Appearance  
Aes Screen I #7 (0.1 M sodium cacodylate trihydrate  
pH 6.5 and 1.4 M sodium acetate trihydrate) 
Crystals 
Screen I #20 (0.2 M ammonium sulfate, 0.1 M 
sodium acetate trihydrate pH 4.6, and 25% w/v 
PEG 4000) 
Small plate 
Screen II # 31 (0.1 M HEPES pH 7.5 and 20% v/v 
Jeffamine M600) 
Square crystal 




 Since crystals obtained with Crystal Screen condition #7 (0.1 M sodium 
cacodylate trihydrate pH 6.5, 1.4 M sodium acetate trihydrate) were single, well-shaped, 
and larger than others, suggesting better ordered crystals, this condition was chosen for 
optimization so as to obtain better crystals of Aes for data collection (Figure 2-9).  In 
order to achieve this, the concentration of Aes, temperature, pH range and the amount of 
reagents were varied.  As a result of these trials, crystals with better quality, which were 
able to be used for X-ray crystallography, were produced and reproduced as shown in 
Figure 2-10.  According to trials related to temperature for nucleation and crystal growth, 
rapid nucleation occurred and crystals grew faster at low temperature.  Aes crystals 
appeared in about 5 days and grew to their final size (usually 0.45 x 0.35 x 0.15 mm3) in 




Figure 2-9.  The result of crystal screening for Aes.  (A) Crystal of Aes (5 mg/mL) 
formed in Crystal Screen (Hampton Research) condition #7 (0.1 M sodium cacodylate 
trihydrate pH 6.5 and 1.4 M sodium acetate trihydrate) at RT.  (B) Crystals of Aes (5 
mg/mL) formed in the same reagent at 4 °C.  It took less time for nucleation and more 





Figure 2-10.  Crystals of Aes after 
optimization.  (A) Crystals formed in a 
week with 0.10 M sodium cacodylate pH 
6.5, 0.98 M sodium acetate, and 5 µL (10 
mg/mL Aes) / 5 µL (reservoir solution) at 
RT.  (B) Crystals formed in a week with 
0.10 M sodium cacodylate pH 6.5, 1.4 M 
sodium acetate, and 2.5 µL (5 mg/mL 
Aes) / 3.5 µL (reservoir solution) at 4 °C.  
(C) Crystal formed in a week with 0.103 
M sodium cacodylate pH 6.5, 1.4 M 
sodium acetate, and 3 µL (10 mg/mL 
Aes) / 3 µL (reservoir solution) at 4 °C.  








The number of crystals obtained at RT was less than that of crystals at 4 °C but 
were better shaped.  However, crystals formed at RT did not diffract with high resolution.  
The concentration of Aes used in crystallization was also varied from 1.5 mg/mL to 10 
mg/mL to investigate the effect of concentration on nucleation and crystal growth.  As 
the concentration increases, both nucleation and precipitation occur rapidly especially at 
4 °C.  As shown in Figure 2-10, many clusters rather than single crystals were observed 
and crystals also seemed to be cracked when 10 mg/mL of Aes was used.  Trials 
suggested that protein concentration and temperature had a large effect on nucleation and 
crystal growth of Aes with these reagents.  Crystals with different shapes from the same 
reagents were obtained; the shapes of the crystals were triangular, octahedral, or rod but 
all the crystals were colorless (Figure 2-10).  Crystals of Aes were stable and could bear 
complete data collection. 
 
2.3.4 X-Ray Crystallography 
 A couple of the many crystals examined diffracted moderately and three of them 
diffracted to a resolution of 2.7 – 2.8 Å that was considered decent for further data 
collections.  Data were collected from three crystals that consisted of the full-length Aes 
protein with an N-terminal tag containing six histidines in a row: His6-Aes1, His6-Aes2, 
and His6-Aes3.  X-ray data collection statistics are summarized in Table 2-6.  According 
to the data analysis, space groups were determined to be rhombohedral (R3 or R32) and 
tetragonal (P41).  The space group of His6-Aes1 was determined to be R3 with two 
molecules in the asymmetric unit, that of His6-Aes2 was P41 with six molecules in the 
asymmetric unit (Table 2-6), and that of His6-Aes3 was R32 with one molecule per 
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asymmetric unit (data not shown due to uncertainty).  For His6-Ae 2, the Matthew’s 
coefficient suggested a range from 6 to 8 as being optimal and molecular replacement 
using acetyl esterase from Salmonella typhimurium (PDB code: 3ga7, 70% identity) in 
PHENIX [56-57] found only 6 molecules. 
 
Table 2-6.  Statistics of X-ray data collections for His6-Aes. 






0.1 M sodium cacodylate pH 
6.8, 1.4 M sodium acetate, 5 
µL/3 µL, at 4 °C 
0.1 M sodium cacodylate pH 
6.6, 1.4 M sodium acetate, 5 
µL/3 µL, at 4 °C for three 
months and left at RT for a 
day  
Resolution limit (Å) 2.71 2.82 
Wavelength (Å) 1.5418 1.5418 
Unit cell parameters 
(Å, degree) 
a=113.7, b=113.7, c=151.8, 
α=β=90, γ=120 
a=113.6, b=113.6, c=284.7, 
α=β=γ=90 
Space group R3 P41 
Reflections 180082 335684 
Unique reflections 20063 83938 
Completion (%) 99.6 96.8 
Redundancy 8.9 3.9 
Rint 0.1240 (0.4395)
1 0.1446 (0.3034)2 
I/σI 10.93 (2.07)1 7.75 (1.68)2 
Number of molecules 
in asymmetric unit 
2 6 
1 Value in parentheses was for highest resolution bin 2.8-2.7. 
2 Value in parentheses was for highest resolution bin 2.9-2.8.  
 
At the beginning, molecular replacements were performed to determine the initial 
phases by using the homologous proteins 1JJI (29% identity), 1EVQ (26%), 1QZ3 (26%) 
and 2C7B (27%) that were available from the PDB, but the trials were not successful.  
However, 3GA7, the Aes from Salmonella typhimurium, had been recently determined 
and with the percent identity to Aes being 70%, was successful in providing the initial 
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phases of Aes.  The data from His6-Aes2, which crystallized in the tetragonal space group 
P41, led to the structure determination of Aes.  Moreover, the initial phases of R3 were 
found but the refinement did not go well and stuck with high R-factors probably because 
of twining.  Therefore, the model was built using the data from His6-Ae 2. 
 
After the molecular replacement solution was found, some of the amino acids for 
the search molecule were converted to correspond to the ones in Aes from Escherichia 
coli since the initial model was based on the homologous protein used in molecular 
replacement.  Afterward, the side chain of 32 residues (Leu-7, Asp-11, Leu-12, Lys-18, 
Leu-24, Gln-25, Thr-45, Leu-46, Glu-57, Gln-71, Glu-73, Asp-82, Gln-115, Ile-138, His-
146, Gln-148, Glu-150,Asp-151, Gln-153, Ile-154, Met-156, Arg-158, Asp-184, Lys-187, 
Arg-201, Val-212, Trp-213, Gln-218, Gln-219, Glu-226, Glu-250, Lys-302, Glu-306, 
Arg-309, and Gln-313) in chain A was initially truncated into alanine due to poor density 
around the side chain of these residues.  Moreover, residues of a loop (Pro-26, Asp-27, 
Leu-28, Pro-29, Pro-30, Trp-31, Pro-32, Ala-33, Thr-34, and Gly-35) in chain A were 
removed due to the poor electron density since residues 26-35 in 3GA7 were missing. 
 
 Almost all of the residues were built in five rounds of refinement except for the 
loop region of the N-terminal cap, residues 26 to 35, which showed poor density.  In 
order to build this region, each amino acid was manually built with COOT to fit to the 
electron density map, obeying proper geometry.  After the manual refinement, all six 
molecules were refined with PHENIX with simulated annealing, TLS and modified NCS 
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that excluded the loop region mentioned above and amino acids 217-219 and 247-250 
that showed relatively weak electron density among the molecules in the asymmetric unit 
and slightly different orientation for the amino acids.  Molprobity was performed to 
validate the structure of Aes (Table 2-7).  According to the comprehensive validation, 
there were still a few residues that were out of the preferred region in the Ramachandran 
plot (see Table 2-8) and unique rotamers for each chain (see Table 2-9). 
 
Table 2-7.  Model validation by Molprobity in PHENIX. 
Geometry outliers 1 residue 
Ramachandran  Favored  94.7% 
Outliers 0.7% 
Rotamer outliers 5.9% 
C-β outliers 0 
Clashscore 24.68% 
 
Table 2-8.  Ramachandran outliers for each chain.  The number is the residue 
number of Aes. 
Chain A 30, 32 
Chain B 26 
Chain C 32 
Chain D 34, 35 
Chain E 29, 33, 35, 36 
Chain F 30, 31, 36 
 
Table 2-9.  Unique rotamers for each chain.  The number is the residue number of 
Aes. 
Chain A 17, 23,42, 45, 60, 110, 217, 232, 265, 269, 298, 299, 304, 316, 318 
Chain B 17, 37, 39, 42, 46, 60, 68, 110, 218, 219, 232, 248, 249, 265, 269, 298, 
299, 303, 316, 318 
Chain C 17, 23, 24, 39, 42, 46, 60, 68, 110, 232, 265, 269, 298, 299, 303, 316, 318 
Chain D 17, 23, 24, 28, 36, 39, 42, 46, 60, 68, 110, 232, 265, 269, 298, 299, 303, 
316, 318 
Chain E 17, 23, 24, 28, 31, 34, 36, 39, 42, 46, 60, 64, 68, 110, 232, 265, 269, 298, 
299, 303, 316, 318 





 The crystal structure of Aes is shown in Figure 2-11 and the model statistics are in 
Table 2-10.  X-ray crystallography revealed that Aes contained a typical α/β hydrolase 
fold with the central β-strands surrounded by α-helices.  There are eight β-strands (β1: 
Thr-60 to Val-65, β2: Val-72 to Phe-77, β3: Thr-86 to Leu-90, β4: Thr-117 to Ile-121, 
β5: Arg-158 to Asp-164, β6: Gly-190 to Trp-194, β7: Cys-254 to Ala-259, β8: Cys-282 
to Tyr-287) and thirteen α-helices (α1: Val-9 to Leu-12, α2: Ala-15 to Asn-22, α3: Ile-37 
to Asn-52, α4: Leu-100 to Ser-114, α5: Gln-133 to Tyr-152, α6: Ala-166 to Lys-181, α7: 
Val-204 to Leu-208, α8: Gln-218 to Tyr-228, α9: Asp-232 to Glu-236, α10: Leu-242 to 
Asp-244, α11: Leu-265 to His-278, α12: Phe-294 to Tyr-297, α13: Lys-302 to Gln-318).  
A portion (residues 1-4 and 26-35) of the N-terminal region of Aes from Salmonella 
typhimurium, which was used to determine the initial phases, was not built.  However, in 
this study, residues 26-35 of the Aes from E. coliwere built even though residue 1 and 2 
were unable to be built.  This new finding should help in better understanding the 
structure and function of homologous proteins.  The current model consists of six 
molecules in the asymmetric unit with 1902 amino acid residues.  The residuals are Rwork 
= 19.79% and Rfree = 26.46% (Table 2-10).  The N-terminal residues were disordered and 
not modeled, including the His6 tag (36 amino acids including six histidines) and some 
N-terminal residues of Aes (residues 1 and 2).  However, the C-terminal residues were 
ordered enough to be modeled.  The N-terminus of Aes was highly flexible, suggesting 





Figure 2-11.  X-ray crystal structure of Aes generated by 
diagram of the Aes structure
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Table 2-10.  Statistics for the model of His6-Aes2. 
Resolution 2.8 
Rwork (%) 19.79 
Rfree (%) 26.46 
r.m.s bond deviation (Å) 0.008 
r.m.s angle deviation (°) 1.072 
Number of amino acid residues 1902 
Number of water molecules 0 
B-factor for all atoms (Å) 60.7 
  
Rwork = Σ|Fobs - Fcalc|/Σ |Fobs|, where summation is over data and Rfree contains only 
1.1% of data excluded from all refinement. 
 
 According to the three dimensional structure of Aes, a catalytic triad is present 
consisting of Ser-165, Asp-262 and His-292 (Figure 2-11).  The catalytic triad is located 
near the C-terminus in three different loop regions between an α-helix and a β-strand 
(Figure 2-11).  More specifically, Ser-165 is located between β5 and α6, Asp-262 is 
located between β7 and α11, and His-292 is located between β8 and α12.  His-292 
interacts with Ser-165 and Asp-262 with a distance of 3.2 Å and 2.9 – 3.3 Å respectively 
(see Figures 2-12 and 2-14).  Another motif of Aes, HGGG (histidine-glycine motif), is 
found between α4 and β4 (see Figures 2-12 and 2-14).  The N-terminus is composed of a 
long loop consisting of three relatively short α-helices (α1, α2, and α3) (Figure 2-12).  
The second β-strand (β2) is anti-parallel to the others, which leads to the formation of the 
α/β hydrolase fold where the central eight β-strands (β1, β2, β3, β4, β5, β6, β7, and β8) 
are surrounded by α-helices (α4, α5, α6, α11, α12, and α13).  Moreover, there is another 
loop with α-helices (α7, α8, α9, and α10) between β6 and β7, which may provide the 
flexibility and selectivity for substrates of Aes.  A total of six molecules were found in 
COOT arranged as three dimers in the asymmetric unit (Figure 2-12).   
 
Figure 2-12.  A view of 
are shown.  Figure was produced by PyMOL 
E, chain B forms a dimer with chain D, and chain C forms a dimer with chain F.
 
A dimer is shown perpendicular to the 2
180˚ rotation (Figure 2-13
surfaces and assemblies service PISA at European Bioinformatics Institute) that predicts 
the quaternary structures of protein
chain C and F (CF) form stable 
25000 Å2 and buried area 2140 
buried area of BD is slightly larger than 
dimers (AE and CF).  According to structural studies on homologous proteins used in 
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Figure 2-13.  The dimer of Aes, 
crystallized in P41, and those of 
homologous proteins.  Besides Aes, 
several homologous proteins used in 
molecular replacement and MSA have 
dimers in the asymmetric
individual molecules of the dimer are 
related by a two fold axis
(A) Aes (three dimers in the asymmetric 
unit), (B) 2C7B (one dimer), (C) 1JKM 
(one dimer), (D) 1JJI (two dimers), and 
(E) 3DNM (two dimers).  They have an 





 unit.  The 
 (a black oval). 
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Table 2-11.  Analysis of protein interfaces.  Chain A (A) forms a dimer with chain 
E (E), chain B (B) forms a dimer with chain D (D), and chain C (C) forms a dimer 
with chain F (F), which are consistent to the finding from the crystal structure of Aes 
in the asymmetric unit (Figure 2-12).  According to the PISA analysis, these dimers 
are stable in solution. 
Composition Surface area, Å2. Buried area, Å2. 
AE 24850 2140 
BD 24560 2240 
CF 25000 2100 
 
 Since Aes was crystallized at pH 6.6, Asp (pKa=3.65) is deprotonated and Ser 
should be protonated and a hydrogen atom on His-292 binds to the oxygen atom on Asp-
262 and a nitrogen atom (ε2N) of His-292 binds to the hydrogen atom on Ser by hydrogen 
bonding (see Figures 2-14 and 2-15).  X-ray crystallography also revealed that the 
catalytic triad of Aes is stabilized by weak hydrogen bonds formed between Ser-165 and 
the backbone residues of the HGGG motif (see Figures 2-14 and 2-15).  In addition to 
these residues, there are several His and Asp residues around the active site of Aes.  They 
probably are involved in hydrogen bonding to stabilize the active site (Figure 2-15).  
Moreover, there are several positive densities around the active site but identifications of 
them are still undetermined due to low resolution (Figure 2-14). 
 
Figure 2-14.  The view around the catalytic triad and HGGG motif with electron 
density map.  The protein coordinate is shown as yellow sticks, electron density map
(rendered 1σ) is shown as blue grids, and positive density is shown as orange grids.  
His-292 binds to Asp-262 and Ser
and Ser-165 is stabilized by 
(γO) of Ser-165 and the 
hydrogen atom of Ser-165 and




-165 by hydrogen bonding (shown in 
hydrogen bonds that forms between the oxygen atom 
nitrogen atom (blue of sticks) of glycines from HGGG













Figure 2-15.  The view around the 
yellow sticks.  There are several residues that are involved in the stabilization of the 
active site through hydrogen bonds (dashed line).  Asp
and His-296 through relatively strong hydrogen bonds and also His
by Tyr-195 through a weak 
catalytic triad is stabilized.
 
 Moreover, according to the multiple sequence alignment (MSA) performed by 
ClustalW [76], the HG G
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sensitive lipase like Este5 from a metagenome library (PDB ID: 
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-296 is stabilized 
hydrogen bond.  Because of these hydrogen bonds, the 
 
 motif (residue 91, 92, 93, and 94 in Aes) and residues of the 
-292) are both highly conserved among bacterial 
3FAK) and 
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bacteria, the nucleophile such as Asp or Glu should be necessary for such hydrolases to 
function.  Moreover, there are some highly conserved residues; His-103, Asp-122, Pro-
132, and His-252.  Asp-122, Pro-132, and His-252 are found in the loop region, while 
His-103 is found on an α-helix.  According to the structural studies using PyMOL, His-
103 stabilizes Gly-92 (4.1 Å) and Asp-122 is also involved in the stabilization of His-91 
(4.1 Å) by hydrogen bonds. 
 
 
Figure 2-16.  Multiple sequence alignment of Aes to homologous proteins.  3GA7 
is an acetyl esterase from Salmonella typhimurium, 1JJI is a hyper-thermophilic 
carboxylesterase from Archaeoglobus fulgidus, 2C7B is a new thermophilic and 
thermostable carboxylesterase cloned from a metagenomic library, 1EVQ is a 
thermophilic carboxylesterase Est2 from Alicyclobacillus acidocaldarius, 1QZ3 is a 
mutant M211S/R215L of a carboxylesterase Est2 complexed with 
hexadecanesulfonate, 3FAK is a hormone-sensitive lipase like Este5 from a 
metagenomic library, 3DNM is a hormone-sensitive lipase from a metagenomic 
library, and 1JKM is a brefeldin A esterase, a bacterial homologue of human 
hormone-sensitive lipase.  Some homologous proteins are used in molecular 
replacement to find the search model in molecular replacement.  The name 
 
corresponds to the name used in PDB except for HSL_hum and HSL_Rat.  
HSL_hum refers to HSL from 
Rattus norvegicus.   
 
The catalytic triad and 
surrounded by hydrophobic residues
them by hydrophobic interactions.
the triad (Figure 2-17).  Therefore, the N
perfect lid as reported for other homologous proteins belonging to 
crystal structure is determined with a ligand, it is possible that the loop could move and 
cover the active site. 
 
Figure 2-17.  Hydrophobicity plot of 
catalytic triad is magenta, HGGG motif is blue, and others are white.  Sphere 
representation (A) and surface
terminus.  The catalytic triad and 
partial accessibility from the surface
 
 
 Based on X-ray crystallography, chemical properties around the active site of Aes 
and the mechanism of serine protease and 
(A) 
56 
Homo sapiens and HSL_Rat refers to HSL from 
HGGG motif are found in a cleft, of the molecule
, where a flexible loop of the N-terminus
  However, it seems that there is partial accessibility to 
-terminal region does not appear to act
the H-
 
Aes.  Hydrophobic residues are green, the 
 representation (B) of Aes viewed from the 
HGGG are hidden in the shallow cleft 
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be proposed as shown in Figure 2-18.  Since the actual substrate for Aes in E. coli is still 
unknown, p-nitrophenyl butyrate is used to explain the proposed mechanism.  (1) The 
hydroxyl group (OH group) of Ser-165 attacks the carbonyl carbon of the substrate.  The 
lone pair on the nitrogen atom (ε2N) of His accepts the hydrogen (H) from the OH group 
and a pair of electrons from the double bond of the carbonyl oxygen moves to the oxygen 
atom (O), forming an enzyme-substrate intermediate (2).  (2) The electrons between C-O 
of the substrate attack H of His, leading to the bond formation of O-H on the substrate.  
The electrons on O- move back to recreate the C=O and His is regenerated, releasing p-
nitrophenol (3).  Now, water comes in, attacking the carbonyl carbon, and electrons from 
the C=O double bond move back to O.  Afterward, the bond between O of water and C of 
the substrate is formed and ε2N of His accepts H from water (4).  (5) The electrons 
forming the bond between C-O from Ser attack H on His to reform the OH group on Ser 
and then the double bond is reformed between C=O.  Finally, the carboxylic acid is 
















 As mentioned before, only 3GA7 could work as a successful search model in 
molecular replacement to determine the initial phases.  To understand the reasons why 
the other search models did not work, Aes was superimposed with the homologous 
proteins used in the molecular replacements with the program PyMOL (Figure 2-19).  
Compared to the crystal structures for homologous proteins, one of the reasons why the 
other structures failed in molecular replacement was that Aes has a long loop around the 
N-terminus, which was found to be completely different to the other proteins.  The other 
reason is probably because α11 and β8 in Aes have slightly different conformations 
compared to the others.  Since a flexible loop in the N-terminus of 3GA7 was not built 
and also the identity of 3GA7 was high to Aes, it worked as a good model in molecular 
replacement.  The overall structures of all the homologous proteins are similar, showing 
the α/β hydrolase fold; however, there are slight shifts between Aes and the other 
homologous proteins except for 3GA7.  Moreover, since some structures of homologous 
proteins have a ligand, the catalytic triad proposed in this study is consistent with their 
findings.  Therefore, also in Aes, the cleft mentioned should be the binding pocket for the 
substrate in E. coli and the substrate should be relatively small due to the size of the 
shallow cleft.   
  
 
Figure 2-19.  Comparison of crystal structures of homologous 
Cα RMSD value for 3GA7 was determined by PyMoL with 
chain ChA_aes (pdb file of chain A of Aes)
and name ca. The same procedure was performed for each 
order to obtain Cα RMSD values.  
Cα RMSD = 0.364 Å. (B) Aes is aligned with 1
(C) Aes is aligned with 1
2C7B (black), Cα RMSD = 1.043 
1.061 Å.  (F) 3D alignment of Aes (green) with homologous proteins: 3GA7 
(magenta), 1EVQ (blue), 1QZ3 (orange), 2C7B (black), and 1
are shown as sticks with correspondin
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EVQ (blue), Cα RMSD = 1.375 
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propane-1, 3-diol, that of 1QZ3 is 1-hexadecanosufonic acid, and that of 1JJI is 4-(2-
hydroxyethyl)-1-piperazine ethanesulfonic acid.  The phosphoserine, which is also 




 X-ray crystallography revealed that Aes contained an α/β hydrolase fold, the 
central β-strands being surrounded by α-helices.  Moreover, according to the structural 
analyses and literature review, the catalytic triad of Aes consists of Ser-165, Asp-262 and 
His-292, Ser-165 being stabilized by His-292 through hydrogen bonding.  His-292 is also 
stabilized by Asp-262 by hydrogen bonding.  Aes has a shallow cleft consisting of 
hydrophobic residues, which leading to the substrate binding pocket and the catalytic 
triad.  Aes also has a long loop with short α-helices around the N-terminus, suggesting 
that it acts as a flexible lid that protects a substrate from the environment during the 
catalytic activity.   
 
 As future work, crystallization with a substrate should be performed in order to 
investigate whether there is a conformational change of the structure of Aes with the 
presence of the substrate.  Moreover, the structure determination of Aes using the data of 
His6-Aes1 (R3) should be carried out to see whether there are any structural differences 
compared to the structure from His6-Aes2 (P41).  The co-crystallization with MalT is also 
challenging but worth investigating in order to know how Aes and MalT interact to better 









 The maltose system is a member of the periplasmic binding protein-dependent 
ATP-Biding Cassette (ABC) high affinity transport systems and the maltose regulon 
consists of five operons: malPQ, malS, malEFG, malK-lamB-malM, and malZ [2, 6, 16].  
The malPQ, malS, and malZ encode proteins that play roles in maltose and maltodextrin 
metabolism while the malEFG and malK encode proteins involved in the uptake of 
maltose and maltodextrin (see section 1.3) [14, 16].  The expression of these genes are 
controlled by MalT and since the expression of malEFG and malK-lamB-malM is under 
catabolite repression, these mal genes are controlled by CAP [2, 16].   
 
 MalT from E. coli is a 103 kDa protein and consists of 901 amino acids.  It is a 
transcriptional activator of the maltose regulon, showing a weak ATPase activity [82].  
The activity of MalT is regulated by many different regulatory signals.  MalT is activated 
by ATP and maltotriose [2, 16, 82] while it is down regulated by three proteins, MalK, 
MalY, and Aes [14].  There are three regulators for the expression of MalT: CAP, Mlc 
acting as a glucose inducible repressor, and H-NS (nucleoide-associated protein), that 
adjust the expression of MalT [83-87].  
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 MalK is the ATP biding cassette (ABC) protein that transports maltose and 
maltodextrin and is stimulated by the periplasmic maltose binding protein (MBP) [88].  
MalK consists of two domains, the nucleotide binding domain (NBD) and the residue 
regulatory domain (RD).  NBD shows an α/β motif and binds to ATP while RD displays 
β folds and binds to MalT [88].  MalK sequesters MalT in the inactive form and it 
releases MalT by hydrolyzing ATP when substrates are transported [14].  MalK interacts 
with MalT directly without maltotriose and inhibits binding of maltotriose to MalT [2, 
89]. 
 
 The other regulator MalY belongs to the gene cluster of malIXY and is regulated 
by MalI, in other words, MalY is not controlled by MalT.  The gene cluster, malIXY, is 
conserved among some bacteria but MalY from other bacteria does not function as a 
down-regulator in E. coli [87].  MalY acts as a cystathionase but this enzyme activity is 
not necessary for the down regulation of MalT [14].  MalY and Aes (see Chapter 2) act in 
a similar manner by stabilizing the inactive form of MalT, the monomeric conformation.  
Crystal structures of MalK and MalY have been determined [87-88] and the crystal 
structure of Aes has been determined in this study (see Chapter 2) (see Figures 2-11 and 
3-1).  Interestingly, parts of MalY and MalK show a similar fold to Aes: β- trands 
surrounded by α-helices. 
 
 
 MalT is a relatively 
residues 1-241), domain II (
and domain IV (DT4: residues
interact with several ligands to be either activated or repressed 
on MalT, DT1 is a binding site for ATP which is one of the inducer
ADP, besides maltotriose, is necessary for MalT to be active (to be multimer).  It is 
suggested that ATPase activity of MalT, even though it is slow, 
competition between the positive and negative effectors 
hydrolysis of ATP is not required for the 






Figure 3-1.  Crystal structures of (A) 
Aes, (B) MalY, and (C) MalK.
has the α/β hydrolase fold, the central 
strands being surrounded by 
Interestingly, the black circled areas on 
MalY and MalK seem to show a similar 
fold to Aes. 
large protein consisting of four domains, domain I (
DT2: residues 242-436), domain III (DT3: re
 807-901) [22, 90-91].  Its function is complicat
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transcription) by MalT [15].  The binding site of MalY is DT1 and that of Aes includes 
both DT1 and DT2 [14-15].  DT3, whose structure has been determined [92], is the 
binding site for maltotriose, the second inducer, and DT4 is the DNA binding site [14, 
22].  Since a recent study suggested Aes bound to DT1 or both DT1 and DT2, structural 
studies for DT1, the first two domains from the N-terminus (DT1-DT2), and the whole 
MalT protein have also been conducted in this research. 
 
3.2 Materials and Methods 
 Basically the same methods described in section 2.2 were used for PCR, plasmid 
construction, over-expression, purification, and crystallization with a few changes as 
described below.  PCR was performed in order to amplify DT1, DT1-DT2, and malT 
with primers listed in Table 3-1.  The stop codon was added on each reverse primer 
shown as bold in Table 3-1.  Using these primers, genes of domain I (DT1), and the first 
two domains from the N-terminus (DT1-DT2) were amplified by PCR with the same 
program as used in the PCR amplification of the aes gene (see section 2.2.2).  Since 
amplification did not work for the malT gene with this program, probably because malT 
is a much larger gene compared to the others, a longer extension step was needed to 
obtain the whole gene.  Thus, different PCR cycles were tried (Table 3-2) and the 







Table 3-2.  Program used in minicycler in order to amplify malT by PCR. 
 1st Cycle 2nd - 30th Cycles Final Cycle 
Denaturation 94 ˚C 6 min. 45 sec.  
Annealing 55 ˚C 30 sec. 30 sec.  
Extension 72 ˚C 2 min. 1 min. 10 min. 
 
Table 3-3.  Reactions that led to the production of DT1.  (Volumes are in µL) 
10X Accu Prime PCR Buffer II 5 5 5 5 5 5 5 
malT forward (20 µM) 2 3 3 4 4 4 1 
DT1 reverse (20 µM) 2 3 3 4 4 4 1 
DNA template 1 1 2 1 2 4 1 
Accu Prime Taq Polymerase 1 1 1 1 1 1 1 
Sterile Distilled Water 39 37 36 35 34 32 41 
Total Volume 50 50 50 50 50 50 50 
 
Table 3-4.  Reactions that led to the production of DT1-DT2.  (Volumes are in 
µL) 
10X Accu Prime PCR Buffer II 5 5 5 5 5 
malT forward (20 µM) 2 2 3 4 4 
DT1-DT2 reverse (20 µM) 2 2 3 4 4 
DNA template 1 4 1 1 2 
Accu Prime Taq Polymerase 1 1 1 1 1 
Sterile Distilled Water 39 36 37 35 34 
Total Volume  50 50 50 50 50 
 
 
Table 3-1.  Forward and reverse primers for DT1, DT1-DT2, and malT.  DT1 
consists just of domain I of MalT, DT1-DT2 consists of domains I and II, and malT 
consists of the whole malT gene from E. coli. 
malT forward CACCATGCTGATTCCGTCAAAACTAAG 
malT reverse TTA CACGCCGTACCCCAT 
DT1 forward Same as malT forward 
DT1 reverse CTAGCGTGCCGACTTATGG 
DT1-DT2 forward Same as malT forward 
DT1-DT2 reverse CTATTCAGCACGGGCTAGCA 
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Table 3-5.  Reactions that led to the production of malT.  (Volumes are in µL) 
10X Accu Prime PCR Buffer II 5 5 5 
malT forward (20 µM) 3 1 1 
malT reverse (20 µM) 3 1 1 
 DNA template 1 1 2 
Accu Prime Taq Polymerase 1 1 1 
Sterile Distilled Water 37 41 40 
Total Volume  50 50 50 
 
 After PCR, agarose gel electrophoreses were performed followed by gel 
extraction in order to purify the PCR product from the gel (see section 2.2.2).  Purified 
PCR products were then used in TOPO cloning reactions and transformations, followed 
by analyses of transformants (20 to 30 transformants were analyzed per gene product due 
to high background) using restriction enzymes: SacI and AccI for DT1 and  PstI instead 
of AccI for DT1-DT2 and malT (see sections 2.2.3 and 2.2.4).  Using 1.0% or 0.7% 
agarose gel, agarose gel electrophoreses were performed to analyze plasmids digested by 
the restriction enzymes, followed by DNA sequencing.  After the confirmation of the 
genes being inserted in the plasmids with the correct orientation, each gene (DT1, DT1-
DT2, or malT) was over-expressed in E. coli BL21 StarTM (DE3) in the same manner as 
Aes (see section 2.2.5).  Optimal growth conditions were discovered by conducting time 
course analyses for expression, adding different types of sugars (such as 0.5% maltose 
and 0.5% arabinose) in the LB media and varying the temperature for culturing (18 ˚C, 
28 ˚C, 30 ˚C, 37 ˚C) after induction for each transformant.  Moreover, optimization of the 
solubility of each protein was conducted by adding 0.1 mM, 0.2 mM, 0.5 mM, 1.0 mM, 
and 1.2 mM ATP into the cellular resuspension prior to the disruption of the bacterial 
cells.  Since the yield of bacterial cells producing MalT was low compared to the others, 
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the pLysS E. coli strain, which reduced the basal expression of MalT, was also tried for 
the over-expression of MalT in order to slow the expression of this apparent toxic gene.  
 
 Bacterial cells were harvested in the same manner as for Aes with pellets made 
from 400 mL of bacterial culture that were resuspended in 10 mL of Buffer C (50 mM 
TrisHCl pH 7.8, 500 mM KCl, and 10% sucrose).  After the addition of 0.2 mg/mL or 10 
mg/mL lysozyme in the resuspension, they were incubated at 27 ˚C for 30 minutes.  
Afterwards, centrifuge tubes containing the cell resuspension were placed on ice for at 
least 10 minutes followed by the addition of 0.1 mM - 1.2 mM ATP.  Bacterial cells were 
then disrupted by the sonicator in the same manner as Aes (see section 2.2.6).   
 
Nickel chelate affinity chromatography was performed for DT1, DT1-DT2, and 
MalT with Buffer C.  During purifications, the buffer blender was used in the similar 
manner as Aes (section 2.2.6.) with the Duo Flow System so as to adjust the pH to 7.8.  
After Ni affinity chromatography, either a desalting column or a gel filtration column was 
used to remove the excess amount of imidazole depending on the result of Ni affinity 
chromatography, more specifically, the desalting column was used if no impurities were 
observed on SDS-PAGE while the gel filtration column was used if impurities were 
observed after Ni affinity chromatography.  For either case, 0.1 – 1.2 mM ATP was 
added to the sample prior to the chromatography using Buffer D (50 mM TrisHCl pH 7.8 




Since DT1 and MalT were successfully purified, crystallization screening was 
performed using Crystal ScreenTM I and II, and Index Screen (Hampton Research) with 
the hanging drop vapor diffusion method using 24 well plates (see section 2.2.8).  The 
concentration of DT1 and MalT used in crystal screening was 5 mg/mL according to the 
Bradford assay, and the protein solution was filtered with a 0.20 µm filter.  Reagent (700 
µL) was used for the reservoir and the rest of the procedure was similar to the 
crystallization methods used for Aes, such as the exploration of the size of the droplets 
and temperature (RT and 4 ˚C). 
 
 
3.3 Results and Discussion 
 The plasmids carrying DT1, DT1-DT2 and the malT genes were successfully 
constructed even though only a few of the about 30 transformants tested carried the 
proper recombinant plasmid.  According to DNA sequencing, a point mutation was found 
in DT1 at amino acid residue 182 compared to SwissProt P06993, resulting in Gln (codon 
CAG) to Arg (codon CGG) while no mutations were found in DT1-DT2 and malT.  Time 
course analyses were performed to optimize culturing condition for each protein and 
several results of SDS-PAGE analyses of the optimization are shown in Figure 3-2.  The 
optimal conditions for culturing are summarized in Table 3-6.  Moreover, as a result of 








Figure 3-2.  SDS-PAGE analyses of over-expression of DT1, DT1-DT2, and 
MalT.  An aliquot was obtained from induced and un-induced culture every one 
hour for four to five hours after the induction. Unlabeled lane is a size marker.  (A) 
Time course study of DT1 at 37 ˚C without any sugars, comparing the induced (I) 







I-1 U-1 U-2 U-3 U-4 I-2 I-3 I-4 I-5 
I-1 I-2 I-3 I-4 
I-1 I-2 I-3 
U-1 U-2 U-3 
U-3 U-2 U-1 I-4 
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the hour after the induction) and over-expressed in 5 hours after the induction.  (B)  
Time course analysis of DT1-DT2 at 37 ˚C, comparing the induced and the un-
induced whole cell.  DT1-DT2 was over-expressed in 4 hours after the induction.  
(C) Time course analysis of MalT at 37 ˚C, comparing the induced and the un-
induced whole cell.  MalT was over-expressed in 4 hours after the induction.  
  
 DT1 and MalT were successfully purified by chromatography as shown in 
Figures 3-3, 3-4, 3-5, and 3-6.  Since there were impurities observed on a SDS-PAGE gel 
after Ni affinity column chromatography of DT1, a gel filtration column was used to 
obtain pure DT1.  On the other hand, impurities were negligible on a SDS-PAGE gel 
after Ni affinity column chromatography of MalT, a desalting column was used to 
exchange buffer.  DT1-DT2 was unable to be purified and the reason might be because 
six-histidine tag is hidden in the protein molecule due to the disorder and so unable to 
bind to the Ni affinity column during purification since DT1-DT2 flows through without 
any imidazole.   
Table 3-6.  Optimal conditions for culturing in order to obtain high yield of each 
protein. 
Protein Name 
Growth condition after the induction by 1.0 mM IPTG at OD600 = 
0.6. 
DT1 18-20 hours of incubation at 28 ˚C. 
DT1-DT2 5 hours of incubation at 28 ˚C. 






Figure 3-3.  Chromatogram generated by Bio-Rad DuoFlow as a result of gel 
filtration column purification of DT1.  DT1 was eluted into test tubes # 22 and 23 
and samples #1 to 9 were used in SDS-PAGE analysis.   
 
 
Figure 3-4.  SDS-PAGE analysis of DT1 purified by gel filtration column 
chromatography after Ni affinity column chromatography.  DT1 was eluted with 
500 mM imidazole followed by the gel filtration column chromatography since 
impurities were observed.  First lane from the left contains size marker and the 
numbers for each lane correspond to the sample number on the chromatogram.  
Samples # 5 and 6 were used in crystallization. 
 






Figure 3-5.  Chromatogram generated by Bio-Rad DuoFlow as a result of  
Ni affinity column purification of MalT.  Impurities are mostly eluted at the 
beginning as flow through, indicated by the elevation of the blue line from test tube 
#1 to #13.  MalT is eluted around 150 mM imidazole into test tube #29 to #33.  
Samples labeled as #1 to #18 were used in SDS-PAGE analysis. 
 
 
Figure 3-6.  SDS-PAGE analysis of MalT purified by Ni affinity column 
chromatography.  15% SDS-PAGE gel stained with Coomassie blue.  First lane 
from the left contains size marker and the numbers for each lane correspond to the 
sample number on the chromatogram.  MalT was eluted with about 150 mM 
imidazole and the amount of impurities was negligible.  Samples # 12 - 14 were 
pooled and used in further purification by a desalting column. 
 
 Based on the screening (Table 3-7 and Figure 3-7), the optimization of 
crystallization condition for DT1 and MalT was conducted as follows.  Initially, for DT1, 
since crystals were found in Index #68 were relatively larger than the others and all 
reagents in Index #68 (Jaffamine M-600 consists of O-(2-aminopropyl)-O’-(2-





methoxyethyl)polypropylene glycol 500 and polypropylene glycol 500 mono-2-
aminoethyl mono-2-methoxyethyl ether) were available, optimization was tried by 
varying the concentration of protein sample in a droplet (5-10 mg/mL of protein sample 
was used to prepare various sizes of droplets), the pH ranged from 7.2 to 7.7, and the 
trays were tried at temperatures 4 °C and RT.  Moreover, the pH (7.8 or 8.8) during 
purification was varied in order to see whether it affected crystallization of DT1.  As a 
result, larger needles were obtained with the protein purified at pH 8.8 and they were 
more separated in reservoirs with 7.5, 7.6 and 7.7 compared to the original conditions.  
However, they were not large enough for data collection.  Therefore, optimization using 
Index #38 or #76 were also tried in order to obtain single crystals for data collection of 
DT1.  So far, large single crystals have not been obtained even though the size of the 
crystals has been improved after optimization.  In order to obtain better crystals of DT1, 
some trials should be performed such as changing the type of buffer for purification, the 
amount of ATP, and also using different crystallization buffers that led to the crystal 









Table 3-7.  Crystallization conditions that led to the formation of crystalline 
material or small crystals for DT1 and MalT within a month.  
Protein Name Preliminary Crystallization Condition Appearance  
DT1 Screen I #40 (0.1 M sodium citrate tribasic dehydrate 
pH 5.6 and 25% v/v 2-propanol) 
Needles 
Index #37 (25% w/v PEG1500) Crystalline 
Index #38 (0.1 M HEPES pH 7.0 and 30 % v/v 
Jeffamine M-600 pH 7.0) 
Crystalline 
Index #66 (0.2 M ammonium sulfate, 0.1 M BIS-Tris 
pH5.5 and 25% w/v PEG) 
Needles 
Index #67 (0.2 M ammonium sulfate, 0.1M BIS-Tris 
pH 6.5, and 25% w/v PEG 3350) 
Needles 
Index #68 (0.2 M ammonium sulfate, 0.1 M HEPES 
pH 7.5, and w/v 25% PEG 3350) 
Needles 
Index #74 (0.2 M lithium sulfate monohydrate, 0.1 M 
BIS-Tris pH 5.5, and w/v 25% PEG3350) 
Needles 
Index #75 (0.2 M lithium sulfate monohydrate, 0.1 M 
BIS-Tris pH 6.5, and w/v 25% PEG3350) 
Needles and 
plates 
Index #76 (0.2 M lithium sulfate monohydrate, 0.1 M 




MalT Screen II #1 (2.0 M sodium chloride and 10% w/v 
PEG6000) 
A tiny plate 




Index #29 (60% v/v Tacsimate pH 7.0) Crystalline 
Index #33 (1.1 M sodium malonate pH 7.0, 0.1 M 












Figure 3-7.  Crystals or crystalline like 
objects found in screening for DT1 and 
MalT.  (A) DT1 in Index #38.  (B) MalT 
in Index#33. (C) MalT in ScreenII #38. 
 
 Based on the screening (Figure 3-7), the optimization of the crystallization 
condition for DT1 and MalT was conducted as follows.  Initially, for DT1, since crystals 
were found in Index #68 were relatively larger than the others and all reagents in Index 
#68 (Jaffamine M-600 consists of O-(2-aminopropyl)-O’-(2-methoxyethyl)polypropylene 
glycol 500 and polypropylene glycol 500 mono-2-aminoethyl mono-2-methoxyethyl 
ether) were available, optimization was tried by varying the concentration of protein 
sample in a droplet (5-10 mg/mL of protein sample was used to prepare various sizes of 
droplets), the pH range from 7.2 to 7.7, and the trays were tried at temperatures 4 °C and 
RT.  Moreover, the pH (7.8 or 8.8) during purification was varied in order to see whether 
it affected crystallization of DT1.  As a result, larger needles were obtained with the 
protein purified at pH 8.8 and they were more separated in reservoirs with 7.5, 7.6 and 
7.7 compared to the original conditions.  However, they were not large enough for data 





obtain single crystals for data collection of DT1.  So far, large single crystals have not 
been obtained even though the size of the crystals has been improved after optimization.  
In order to obtain better crystals of DT1, some trials should be performed such as 
changing the type of buffer for purification, the amount of ATP, and also using different 
crystallization buffers that led to the crystal formation of DT1 in screening (Table 3-7). 
 
 On the other hand, for MalT, even though crystals in Index #38 looked better than 
the others, PEG10000 was not available. Therefore, PEG8000 was used instead of PEG 
10000 to optimize the crystallization condition for MalT by varying the concentration of 
protein sample in the droplet (about 5mg/mL was used to prepare various sizes of 
droplets), the pH ranged from 6.8 to 7.8, the percentage of PEG8000 (20%-32%), and the 
temperature (4 °C and RT).  Moreover, using Tacsimate (Index #29, the mixture of 
1.8305 M malonic acid, 0.25 M ammonium citrate tribasic, 0.12 M succinic acid, 0.3 M 
DL-malic acid, 0.4 M sodium acetate trihydrate, 0.5 M sodium formate, and 0.16 M 
ammonium tartrate dibasic), the optimization was performed at RT by altering the 
percentage of Tacsimate (from 50% to 70%) in the reservoir solution.  Crystals were 
formed in a few weeks at 4 °C and in a month to a few months at RT (Figure 3-8).  
Initially, good precipitates and small crystalline like objects were observed in droplets 
that led to the formation of these crystals.  However, it took a few weeks to months for 
these crystals to grow in the droplets.  As a result, reservoir solutions whose droplets 
contained crystals were almost dried out when they were examined by X-ray diffraction.  
Crystals in Figure 3-8 were mounted on the X-ray diffractometer but did not diffract 
(simple scan by Dr. Leonard M. Thomas at the University of Oklahoma Macromolecular 
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Crystallography Laboratory).  It is possible that crystals shown in Figure 3-8 are just salt 
or proteins that had just lost the order of the protein.   
 
  
Figure 3-8.  Crystals found in optimizing the MalT crystallization.   (A) Crystals 
in a droplet containing 3 µL MalT (1 mg/mL) and 3 µL reservoir solution (60% 
Tacsimate) at RT.  (B) Crystals in a droplet containing 3 µL MalT (1mg/mL) and 3 
µL reservoir solution (65% Tacsimate) at RT. 
 
 Further investigations with these conditions are necessary to examine whether 
crystals obtained in this condition were protein or salt crystals.  Moreover, buffers used in 
the purification should be investigated since in this research only Tris buffers were used 
based on the literature that successfully purified each domain of MalT along with whole 
MalT.  Besides Tris buffer, HEPES, citrates and others may work better to purify these 
proteins and affect their crystallization.  In addition to buffer conditions, crystallization 
conditions should be further investigated based on the screening since some reagents 
were not available at that time and thus some conditions listed in Table 3-7 were not 





 Since crystals of DT1 or MalT have not been obtained, preliminary structural 
studies have been performed by modeling DT1 based on the sequence using web servers, 
SWISS-MODEL (an automated comparative protein modeling server) [93-95] and Phyre 
(protein homology/analogy recognition engine) [96] (Figure 3-9).  SWISS-MODEL 
generated a segment, a model 1 (residues 32 to 68), based on the crystal structure of the 
putative gluconate kinase from Bacillus halodurans (PDB ID: 2BDT and sequence 
identity = 34.375%) with Expect value (E-value) = 2.90e-5 and a model 2 (residues 9 to 
225) based on the crystal structure of RuvB complexed with RuvA (Holliday junction 
DNA helicases) domain III from Thermus thermophilus (1IXS and identity = 14.041%) 
[97] with E-value = 8.9e-12.  On the other hand, Phyre generated ten models with better E-
value that is a factor showing the number of hits one can expect to see by chance [98].  A 
model 3, d2fnaa2 (residues 10 to 237), was generated based on P-loop containing 
nucleoside triphosphate hydrolases (identity = 12%) with E-value = 1.2e-18, which belong 
to the Family AAA-ATPase domain.  A model 4, c2fnaB (residues 10 to 237), was 
generated based on the conserved hypothetical protein from Sulfolobus solfataricus 
(identity = 12%) with E-value = 9.9e-18.  A model 5, c2a5yB (residues 8 to 236), was 
generated based on the crystal structure of apoptosome from the Caenorhabditis elegans 
(CED4, identity = 12%) with E-value = 2.2e-16   According to these models, DT1 may 
consist of α-helices with a few β-strands.  However, since residue 60 and 61 are not 
connected in model 3 and model 4 while a β-strand is present around these residues of 
model 4, there are differences among these models even though they look similar.  
Therefore, further investigation is necessary to understand the structure of DT1 and how 
DT1 interacts with Aes.  Moreover, Phyre and SWISS-MODEL were also used for 
 
modeling MalT and DT1-
same as model 1 to 5, were generated. 
Figure 3-9 Models of DT1.
DT1.  (A) and (B) were generated by SWISS
generated by Phyre.  (A) M
gluconate kinase from Bacillus halodurans
value) = 2.90e-5.  (B) Model 2 was based on the crystal structure of RuvB complexed 
with RuvA (Holliday junction DNA helicases) domain III from 
(1IXS).  (C) Model 3 was generated by Phyre, based on 
nucleoside triphosphate hydrolases.  (D) M
hypothetical protein from 
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 The plasmids carrying DT1, DT1-DT2, and malT were constructed and DT1, 
DT1-DT2, and MalT were successfully over-expressed in E. coli in this study.  Moreover, 
DT1 and MalT were also successfully purified and as a result of crystallization screening, 
there were some conditions that led to the formation of small crystals or crystalline like 
objects, which were necessary to be optimized so as to obtain single crystals that diffract 
and lead to the crystal structure determination of these proteins.  Current work with some 
conditions is quite promising.  Therefore, continued work in optimizing conditions listed 
in section 3.3 will lead to the structure determination of these proteins.  The purification 
of DT1-DT2 should be also investigated so as to purify DT1-DT2 since this region is a 
critical part in the binding of Aes and ATP.  The crystal structure determination of this 
part should help understanding the relationship between Aes and this region of MalT.  
Moreover, since the crystal structure of DT3 has been determined [92], crystal structure 
determination of DT1-DT2 will lead to understanding of the structure of MalT and 
subsequently the interaction between Aes and MalT.  Purification condition for them can 
also be optimized using different types of buffers such as HEPES, which may lead to 
higher yield of these proteins, especially MalT since the yield of MaT is quite low 
compared to other proteins studied in this research.  Co-crystallization of these proteins 
and Aes is challenging but worth trying in order to obtain co-crystals to understand how 
they interact.  Moreover, according to preliminary models of DT1 obtained using Phyre, 
DT1 may contain α-helices with a few β-strands and model 3 might be close to the crystal 
structure of DT1 since DT1 shows week ATPase activity as its template.  However, since 
there are differences among these models further investigation is necessary to conclude 
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the plausible model of DT1 and know how DT1 interacts with Aes.  Moreover, structural 
studies of MalT and DT1-DT2 based on the sequence using SWISS-MODEL [93-95] 
with MSA and docking between Aes and these proteins can be investigated further in 








 This dissertation reports the cloning, over-expression, purification, crystallization 
and crystal structure analysis of Aes that belongs to the HSL family and is a down 
regulator for MalT which is a transcriptional activator of the maltose regulon (Chapters 2 
and 3).  Aes acts as an acetyl esterase and a recent study suggests an interaction occurs 
between Aes and α-galactosidase, which is involved in the hydrolysis of α-linked-
galactosides such as those found in the more complex sugars raffinose and melibiose.  
Since Aes plays critical roles in carbohydrate metabolism, especially in the notable 
maltose system in E. coli, the crystal structure determination of Aes will help 
understanding the structures of homologous proteins and also lead to better understanding 
of the maltose system in the future.  In this study, a recombinant Aes in a six histidine tag 
was crystallized (the space groups were R3, and P41) and the data set was obtained with 
the range from 2.7 to 2.8 Å.  The crystal structure of Aes was determined using PHENIX 
and COOT (see section 2.3.4).  X-ray crystallography revealed that Aes contained an α/β 
hydrolase fold similar to homologous proteins whose structures have been determined.  
Moreover, according to the structural analysis and literature review, the catalytic triad of 
Aes consists of Ser-165, Asp-262 and His-292 with Ser-165 being stabilized by His-292, 
which, in turn, is also stabilized by Asp-262 through hydrogen bonding.  Furthermore, 
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Ser-165 is stabilized by weak hydrogen bonding from the HGGG motif.  Aes also has a 
long loop with a few α-helices around the N-terminus and contains a shallow cleft 
consisting of hydrophobic residues, which lead to the substrate binding pocket and the 
catalytic triad.  As mentioned in sections 2.2.10 and 2.3.4, several homologous proteins 
have been used to find the initial phases.  However, acetyl esterase from Salmonella 
typhimurium (PDB code: 3GA7) has been the only structure successful in determination 
of initial phases.  According to the comparison of crystal structures, there are slight shifts 
between Aes from E. coli and the search models except for 3GA7 even though the overall 
structures of all contain the α/β hydrolase fold.  In addition, the N-terminus of all of them 
is highly flexible, leading to the difficulty in finding phases.  The reasons why 3GA7 
worked in molecular replacement is that the area of greatest difference, the loop of the N-
terminus, is not modeled in the structure of 3GA7 and the overall fold of the rest of the 
molecule shows little structural difference with Aes from E. coli(see section 2.3.4).  In 
this study, the loop region around the N-terminus of Aes was built even though some 
residues were still outliers in the Ramachandran plot.  Since the crystal structure of Aes 
was determined in this study including the N-terminal region which should be an 
important part of Aes since it may act as a lid protecting the active site, the findings 
should help further crystal structure determination of homologous proteins, leading to the 
new finding about them.  The ultimate goal is to know how MalT and Aes interact in E. 
coli so as to understand the remarkable maltose system.  Therefore, the crystal structure 
of Aes will lead to this ultimate goal in the future since the knowledge of the structure 




 MalT is the transcriptional regulator for the maltose regulon that is a cluster of 
operons and genes involved in maltose metabolism (see section 3.1).  MalT is activated 
by maltotriose and ATP and inactivated by three proteins; MalK, MalY, and Aes.  Four 
operons involved in the maltose system in E. coliare mostly under the control of MalT.  
Since the crystal structure of DT3 has been determined, besides the crystal structure 
determination of Aes, another aim of this study has been to determine the crystal 
structures of DT1, DT1-DT2, and MalT in order to understand how MalT and Aes 
interact, which play a role in the remarkable maltose system.  To achieve this, plasmids 
carrying each portion of the gene of interest have been constructed and the proteins have 
been over-expressed.  In this study, DT1 and MalT were successfully purified and 
crystallization has also been carried out in this study (section 3.2).  However, high quality 
crystals that diffract well enough for data collection have not been obtained yet.  In order 
to obtain high quality crystals, the following should be investigated for both proteins: 
purification with different types of buffers and further optimization in crystallization 
based on the results of crystal screening.  Moreover, purification of DT1-DT2 will have 
to be investigated with different buffers or methods.  According to preliminary models of 
DT1, DT1 may contain α-helices with a few β-strands.  However, the results were not 
conclusive.  Therefore, further investigation of these proteins in modeling will have to be 








1. Deutscher, J., C. Francke, and P. W. Postma, How phosphotransferase system-
related protein phosphorylation regulates carbohydrate metabolism in bacteria. 
Microbiol. Mol. Biol. Rev., 2006. 70: p. 939-1031. 
2. Gerber, K., X-ray crystallographic studies on Mlc and Aes, two transcriptional 
modulators from Escherichia coli, in Biology. 2005, University Konstanz: 
Konstanz. p. 115. 
3. Voet, D. and J. G. Voet, Biochemistry. Third ed. Chapter 20 Trabsport through 
Membranes, ed. Harris, D., P. Fitzgerald, R. Smith, B. Heaney, S. Dumas, H. 
Newman, E. Rieder, M. Lesure, S. Ingrao, and S. Malinowski. 2004: John Wiley 
and Sons, Inc. 
4. Potsma, P. W., J. W. Lengeler, and G. R. Jacobson, Phosphoenolpyruvate: 
carbohydrate phosphotransferase systems of bacteria. Microbiol. Rev., 1993. 57: 
p. 543-594. 
5. Kuroda, M., T. H. Wilson, and T. Tsuchiya, Regulation of Galactoside 
Transport by the PTS. J. Mol. Microbiol. Biotechnol., 2001. 3: p. 381-384. 
6. Boos, W. and H. Shuman, Maltose/Maltodextrin system of Escherichia coli: 
transport, metabolism, and regulation. Mocrobiol. Mol. Biol. Rev., 1998. 62: p. 
204-229. 
7. Voet, D. and J. G. Voet, Biochemistry. Third ed. Chapter 31 Transcription, ed. 
Harris, D., P. Fitzgerald, R. Smith, B. Heaney, S. Dumas, H. Newman, E. Rieder, 
M. Lesure, S. Ingrao, and S. Malinowski. 2004: John Wiley and Sons, Inc. 
8. Lengeler, J. W., ed. The phosphoenolpyruvate-dependent carbohydrate: 
phosphotransferase system (PTS) and control of carbon source utilization. 
Regulation of gene expression in Escherichia coli., ed. Lin, E. C. C. and A. S. 
Lynch. 1996, R. G. Landes Company: Austin, Texas, USA. 
9. Voet, D. and J. G. Voet, Biochemistry. Third ed. Chapter 5 Nucleic Acids, Gene 
Expression, and Recombinant DNA Technology, ed. Harris, D., P. Fitzgerald, R. 
Smith, B. Heaney, S. Dumas, H. Newman, E. Rieder, M. Lesure, S. Ingrao, and S. 
Malinowski. 2004: John Wiley and Sons, Inc. 
10. Nelson, D. L. and M. M. Cox, Lehninger Principles of Biochemistry. fourth ed. 
2005, New York: W. H. Freeman and Company. 
11. Schlegel, A., A. Böhm, S.-J. Lee, R. Peist, K. Decker, and W. Boos, Network 
regulation of the Escherichia coli maltose system. J. Mol. Microbiol. Biotechnol., 
2002. 4: p. 301-307. 
12. Chapon, C., Role of the catabolite activator protein in the maltose regulon of 




13. Danot, O., D. Vidal-Ingigliardi, and O. Raibaud, Two amino acid residues 
from the DNA-binding domain of MalT play a crucial role in transcripitonal 
activation. J. Mol. Biol., 1996. 262: p. 1-11. 
14. Schlegel, A., O. Danot, E. Richet, T. Ferenci, and W. Boos, The N terminus of 
the Escherichia coli transcription activator MalT Is the domain of interaction with 
MalY. J. Bacteriol., 2002. 184: p. 3069-3077. 
15. Joly, N., O. Danot, A. Schlegel, B. Windried, and E. Richet, The Aes protein 
directly controls the activity of MalT, the central transcriptional cctivator of the 
Escherichia coli maltose regulon. J. Biol. Chem., 2002. 277 No.19: p. 26606-
16613. 
16. Richet, E. and O. Raibaud, Purification and properties of the MalT protein, the 
transcription activator of the Escherichia coli maltose regulon. J. Biol. Chem., 
1987. 262, No.26: p. 12647-12653. 
17. EcoCyc. Escherichia coli K-12 substr. MG1655.  1997  [cited 2009 Wed Oct 14]; 
Available from: http://ecocyc.org/ECOLI/new-
image?type=GENE&object=EG11101. 
18. Keseler, I. M., C. Bonavides-Martines, J. Collado-Vides, S. Gama-Castro, R. 
P. Gunsalus, D. A. Johnson, M. Krummenacker, L. M. Nolan, S. Paley, I. T. 
Paulsen, M. Peralta-Gil, A. Santos-Zavaleta, A. G. Shearer, and P. D. Karp, 
EcoCyc: A comprehensive view of Escherichia coli b ology. Nucleic Acids 
Research, 2009. 37: p. D464-D470. 
19. Kanaya, S., T. Koyanagi, and E. Kanaya, An esterase from Escherichia coli 
with a sequence similarity to hormone-sensitive lipase. Biochem. J., 1998. 332: p. 
75-80. 
20. Hemila, H., T. T. Koivula, and I. Palva, Hormone-sensitive lipase is closely 
related to several bacterial proteins, and distantly related to acetylcholinesterase 
and lipoprotein lipase: identification of a superfamily of esterases and lipases. 
Biochim. Biophys. Acta 
21. Gerber, K., A. Schiefner, P. Seige, K. Diederichs, W. Boos, and W. Welte, 
Crystallization and preliminary X-ray analysis of Aes, an acetyl-esterase from 
Escherichia coli. Acta Crystallogr. D, 2004. 60: p. 531-533. 
22. Richet, E., N. Joly, and O. Danot, Two domains of MalT, the cctivator of the 
Escherichia coli maltose regulon, bear determinants essential for anti-activation 
by MalK. J. Mol. Biol., 2005. 347: p. 1-10. 
23. Peist, R., A. Koch, P. Bolek, S. Sewitz, T. Kolbus, and W. Boos, 
Characterization of the aes gene of Escherichia coli encoding an enzyme with 
esterase activity. J. Bacteriol., 1997. 179. No.24: p. 7679-7686. 
24. Burstein, C. and A. Kepes, The α-galactosidase from Escheirichia coli K12. 
Biochim. Biophys. Acta, 1971. 230: p. 52-63. 
25. Mandrich, L., E. Caputo, B. M. Martin, M. Rossi, and G. Manco, The Aes 
protein and the monomeric alpha-galactosidase from Escherichia coli form a non-
covalent complex. J. Biol. Chem., 2002. 277 No.50: p. 48241-48247. 
26. Brenner, S., The molecular evolution of genes and proteins: a tale of two serines. 
Nature, 1988. 334: p. 528-530. 
27. Winkler, F. K., A. D'arcy, and W. Hunzuker , Structure of human pancreatic 
lipase. Nature, 1990. 343: p. 771-774. 
88 
 
28. Sussman, J. L., M. Harel, F. Frolow, C. Oefner, A. Goldman, L. Toker, and I. 
Silman, Atomic structure of acetylcholinesterase from Torpedo california: a 
prototypic acetylcholine-binding protein. Science, 1991. 253: p. 872-879. 
29. Schrag, J. D., Y. LI, S. WU, and M. Cygler, Ser-His-Glu triad forms the 
catalytic site of the lipase from Geotrichum candidum. Nature, 1991. 351. 
30. Arpigny, J. L. and K.-E. Jaeger, Bacterial lipolytic enzymes: classification and 
properties. Biochem. J., 1999. 343: p. 177-183. 
31. Hulo, N., A. Bairoch, V. Bulliard, L. Cerutti, E. D. Castro, P. S. Langendijk-
Genevaux, M. Pagni, and C. J. A. Sigrist, The PROSITE database. Nucleic 
Acids Res., 2006. 34: p. D227-D230. 
32. PROSITE. 2006, Swiss Institute of Bioinformatics (SIB). 
33. Cousin, X., T. Hotelier, K. Giles, P. Lievin, J.-P. Toutant, and A. Chatonnet, 
The α/β fold family of proteins database and the cholinesterase gene server 
ESTHER. Nucleic Acids Res., 1997. 25, No. 1: p. 143-146. 
34. Krintel, C., C. Klint, H. Lindvall, M. Mörgelin, and C. Holm , Quarternary 
structure and enzymological properties of the different hormone-sensitive lipase 
(HSL) isoforms. PLoS One, 2010. 5: p. e11193. 
35. Yeaman, S. J., Hormone-sensitive lipase - a multipurpose enzyme in lipid 
metabolism. Biochem. Biophys. Acta, 1990. 1052: p. 128-132. 
36. Small, C. A., J. A. Goodacre, and S. J. Yeaman, Hormone-sensitive lipase is 
responsible for theneutral cholesterol ester hydrolase activity in macrophages. 
FEBS Lett., 1989. 247: p. 205-208. 
37. Nedergaard, J. and B. Cannon, Preferential utilization of brown adipose tissue 
lipids during arousal from hibernation in hamsters. Am. J . Physiol., 1984. 247: p. 
R506 - 512. 
38. Langin, D., H. Laurell, L. S. Holst, P. Belfrage, and C. Holm, Gene 
organization and primary structure of human hormone-sensitive lipase: possible 
significance of a sequence homology with a lipase of Moraxella TA144, an 
antarctic bacterium. Proc. Natl. Acad. Sci., 1993. 90: p. 4897-4901. 
39. Holm, C., T. G. Kirchgessner, K. L. Svenson, G. Fredrikson, S. Milsson, C. 
G. Miller, J. E. Shively, C. Heinzmann, R. S. Sparkes, T. Mohandas, A. J. 
Lysis, P. Belfrage, and M. C. Schotz, Hormone-sensitive lipase: sequence, 
expression, and chromosomal localization to 19 cent-q13.3. Science, 1988. 241: p. 
1503-1506. 
40. Osterlund, T., B. Danielsson, E. Degerman, J. A. Contreras, G. Edgren, R. C. 
Davis, M. C. Schotz, and C. Holm, Domain-structure analysis of recombinant 
rat hormone-sensitive lipase. Biochem. J., 1996. 319: p. 411-420. 
41. Wilson, K., Current Protocols in Molecular Biology: Prepartion of Genomic 
DNA from Bacteria, ed. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. 
G. Seidman, J. A. Smith, and K. Struhl. 2003, Townsville, Australia: John 
Wiley&Sons, Inc. 
42. Invitrogen, C., ChampionTM pET Directional TOPO Expression Kits. 2006, 
Carlsbad, CA: Invitrogen Corporation. 1-62. 
43. Promega, C., Technical Bulletin: Wizard Plus Minipreps DNA Purification 
System. 2005, Madison, WI: Promega Corp. 
44. Promega, C., Restriction Enzyme User Manual. 1996-2006. 
89 
 
45. BIO-RAD , Mini-PROTEIN 3 Cell Instruction Manual. 2005, Hercules, CA. 
46. BIO-RAD , BioLogic DuoFlowTM Chromatography System Starter Kit Instruction 
Manual, Hercules, CA. 
47. BIO-RAD , Protein Assay, BIO-RAD, Editor. 
48. Hampton, Crystal Screen - User Guide. 2000-2005, Hampton Research: Aliso 
Viejo, CA. 
49. BRUKER, A., PROTEUM2 User Manual. 2005. 
50. BRUKER , A., PROTEUM crystallographic software suit. 2009. 
51. BRUKER, A., SAINT-NT. 2003: Madison, WI. 
52. Sheldrick, G. M. (2001) XPREP. 
53. Campbell, R. L. Protein function discovery and department of biochemistry 
moleculr modelling and crystallographic computing facility.  2005  [cited 2009 
Nov. 16]; Available from: 
http://pldserver1.biochem.queensu.ca/~rlc/pfd/index.shtml. 
54. Matthews, B. W., Solvent content of protein crystals. J. Mol. Biol., 1968. 33: p. 
491-497. 
55. Collaborative Computational Project, N., The CCP4 suite: programs for protein 
crystallography. Acta Crystallogr. D, 1994. 50: p. 760-763. 
56. Adams, P. D., P. V. Afonine, G. Bunkóczi, V. B. Chen, I. W. Davis, N. Echols, 
J. J. Headd, L.-W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. 
McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. 
Richardson, T. C. Terwilliger, and P. H. Zwart, PHENIX: a comprehensive 
Python-based system for macromolecular structure solution. 2010. 
57. Adams, P. D., R. W. Grosse-Kunstleve, L. W. Hung, T. R. Ioerger, A. J. 
McCoy, N. W. Moriarty, R. J. Read, J. C. Sacchettini, N. K. Sauter, and T. C. 
Terwilliger , PHENIX: building new software for automated crystallographic 
structure determination. Acta Cryst., 2002. D58: p. 1948-1954. 
58. Simone, G. D., V. Menchise, G. Manco, L. Mandrich, N. Sorrentino, D. Lang, 
M. Rossi, and C. Pedone, The crystal structure of a hyper-thermophilic 
carboxylesterase from the archaeon Archaeoglobus fulgidus. J. Mol. Biol., 2001. 
314: p. 507-518. 
59. Byun, J.-S., J.-K. Rhee, N. D. Kim, J. Yoon, D.-U. Kim, E. Koh, J.-W. Oh, 
and H.-S. Cho, Crystali structure of hyperthermophilic esterase EstE1 and the 
relationship between its dimerization and thermostability properties. BMC Struct. 
Biol., 2007. 7. 
60. Simone, G. D., S. Galdiero, G. Manco, D. Lang, M. Rossi, and C. Pedone, A 
Snapshot of a transition state analogue of a novel thermophilic esterase belonging 
to the subfamily of mammalian hormone-sensitive lipase. J. Mol. Biol., 2000. 
303: p. 761-771. 
61. Simone, G. D., L. Mandrich, V. Menchise, V. Giordano, F. Febbraio, M. 
Rossi, C. Pedone, and G. Manco, A Substrate-induced switch in the reaction 
mechanism of a thermophilic esterase. J. Biol. Chem., 2004. 279 p. 6815-6823. 
62. Minasov, G., Z. Wawrzak, J. Brunzelle, O. Onopriyenko, T. Skarina, P. 
Scott, A. Savchenko, and W. F. Anderson, 1.55 Angstrom crystal structure of 
an acetyl esterase from Salmonella typhimurium. 2009, Center for Structural 
Genomics Of Infectious Diseases (CSGID). 
90 
 
63. Simone, G. D., V. Menchise, V. Alterio, L. Mandrich, M. rossi, G. Manco, 
and C. Pedone, The crystal structure of an EST2 mutant unveils structural 
insights on the H-Group of the carboxylesterase/lipase family. J. Mol. Biol., 2004. 
343: p. 137-146. 
64. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, 
I. N. Shindyalov, and P. E. Bourne, The Protein Data Bank. Nucleic Acids Res., 
2000. 28. 
65. Emsley, P. and K. Cowtan, Coot: model-building tools for molecular graphics. 
Acta Crystallogr. D, 2004. 60: p. 2126-2132. 
66. Sayle, R. and E. J. Milner-White, RasMol: Biomolecular graphics for all. 
Trends Biochem. Sci., 1995. 20: p. 374. 
67. Brünger, A. T., Free R value: a novel statistical quantity for assessing the 
accuracy of crystal structures. Nature, 1992. 355: p. 472-475. 
68. Kirkpatrick, S., C. D. G. Jr., and M. P. Vecchi, Optimazation by simulated 
annealing. Science, 1983. 220: p. 671-680. 
69. Cruickshank, D. W., On the lattice vibrations of benzene, naphthalene, and 
anthracene. Rev. Mod. Phys., 1958. 30: p. 163-167. 
70. Schomaker, V. and K. N. Trueblood, On the rigid-body motion of molecules in 
crystals. Acta Crystallogr. B, 1968. 24: p. 63-76. 
71. Rupp, B., Biomolecular Crystallography: Principles, Practice, and Application to 
Structral Biology, ed. Scholl, S. 2009, New York: Garland Science, Taylor & 
Francis Group, LLC. 
72. Davis, I. W., A. Leaver-Fay, V. B. Chen, J. N. Block, G. J. Kapral, X. Wang, 
L. W. Murray, W. B. A. III, J. Snoeyink, J. S. Richardson, and D. C. 
Richardson, MolProbity: all-atom contacts and structure validation for proteins 
and nucleic acids. Nucleic Acids Res., 2007. 35: p. W375-W383. 
73. Painter, J. and E. A. Merritt , Optimal description of a protein structure in terms 
of multiple groups undergoing TLS motion. Acta Crystallogr. D, 2006. 62: p. 
439-450. 
74. Painter, J. and E. A. Merritt , TLSMD web server for the generation of multi-
group TLS models. J. Appl. Cryst., 2006. 39: p. 109-111. 
75. Holm, L., S. Kaariainen, P. Rosenstrom, and A. Schenkel, Searching protein 
structure database with DaliLite v.3. Bioinformatics, 2008. 24: p. 2780-2781. 
76. Larkin, M. A., G. Blackshields, N. P. Brown, R. Chenna, P.A.McGettigan, H. 
McWilliam, F. Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thompson, 
T. J. Gibson, and D. G. Higgins, ClustalW and ClustalX version 2. 
Bioinformatics, 2007. 23: p. 2947-2948. 
77. Koenig, T., B. H. Menze, M. Kirchner, F. Monigatti, K. C. Parker, T. 
Patterson, J. J. Steen, F. A. Hamprecht, and HannoSteen, Robust prediction of 
the MASCOT score for an improved quality aeesssment in mass spectrometric 
proteomics. J. Proteome Res., 2008. 7: p. 3708-3717. 
78. Perkins, D. N., D. J. C. Pappin, D. M. Creasy, and J. S. Cottrell, Probability-
based protein identification by searching sequence database using mass 
spectrometry data. Electrophoresis, 1999. 20: p. 3551-3567. 
79. Pappin, D. J. C., P. Hojrup, and A. J. Bleasby, Rapid identification of proteins 
by peptide-mass fingerprinting. Curr. Biol., 1993. 3: p. 327-332. 
91 
 
80. DeLano, W. L., The PyMOL Molecular Graphics System. 2002, DeLano 
Scientific: San Carlos, CA. 
81. Krissinel, E. and K. Henrick, Inference of macromolecular assemblies from 
crystalline state. J. Mol. Biol., 2007. 372: p. 774-797. 
82. Richet, E. and O. Raibaud, MalT, the regulatory protein of the Escherichia coli 
maltose system, is an ATP-dependent transcriptional activator. EMBO J., 1989. 8: 
p. 981-987. 
83. Tagami, H. and H. Aiba, A common role of CRP in trascription activation: CRP 
acts transiently to stimulate events leading to open complex formation at a diverse 
set of promoters. EMBO J., 1998. 17: p. 1759-1767. 
84. Valerie, S. and E. Richet, Self-association of the Escherichia coli transcription 
activator in the presence of maltotriose and ATP. J. Biol. Chem., 1999. 274: p. 
33220-33226. 
85. Decker, K., J. Plumbridge, and W. Boos, Negative transcriptional regulation of 
a positive regulator: the expression of malT, encoding the transcriptional activator 
of the maltose regulon of Escherichia coli, is negatively controlled by Mlc. Mol. 
Microbiol., 1998. 27: p. 381-390. 
86. Johansson, J., B. Dagberg, E. Richet, and B. E. Uhlin, H-NS and StpA proteins 
stimulate expression of the maltose regulon in Escherichia coli. J. Bacteriol., 
1998. 180: p. 6117-6125. 
87. Clausen, T., A. Schlegel, R. Peist, E. Schneider, C. Steegborn, Y.-S. Chang, 
A. Haase, G. P.Bourenkov, H. D.Bartunik, and W. Boos, X-ray structure of 
MalY from Escherichia coli: a pyridoxal 5'-phosphate-dependent enzyme acting 
as a modulator in mal gene expression. EMBO J., 2000. 19: p. 831-842. 
88. Chen, J., J. Lin, A. L. Davidson, and F. A. Quiocho, A Tweezers-like motion 
of the ATP-binding casette dimer in an ABC transport cycle. Mol. Cell, 2003. 12: 
p. 651-661. 
89. Panagiotidis, C. H., W. Boos, and H. A. Shuman, The ATP-binding cassette 
subunit of the maltose transporter MalK antagonizes MalT, the activator of the 
Escherichia coli mal regulon. Mol. Microbiol, 1998. 30: p. 535-546. 
90. Jain, E., A. Bairoch, S. Duvaud, I. Phan, N. Redaschi, B. E. Suzek, M. J. 
Martin, P. MacGarvey, and E. Gasteiger, Infrastructure for the life sciences: 
design and implementation of the UniProt website. BMC Bioinformatics, 2009. 
10: p. 10-136. 
91. Consorthium, T. U., The Universal Protein Resouce (UniProt) in 2010. Nucleic 
Acids Res., 2010: p. D142-D148. 
92. Steegborn, C., O. Danot, R. Huber, and T. Clausen, Crystal structure of 
transcription factor MalT domai III: a novel helix repest fold implicated in 
regulated oligomerization. Structure, 2001. 9: p. 1051-1060. 
93. Peitsch, M. C., Protein modeling by E-mail. Bio/Technology, 1995. 13: p. 658-
660. 
94. Arnold, K., L. Bordoli, J. Kopp, and T. Schwede, The SWISS-MODEL 
Workspace: A web-based environment for protein structure homology modelling. 
Bioinformatics, 2006. 22: p. 195-201. 
92 
 
95. Kiefer, F., K. Arnold, M. Künzli, L. Bordoli, and T. Schwede, The SWISS-
MODEL Repository and associated resources. Nucleic Acids Res., 2009. 37: p. 
D387-D392. 
96. Kelley, L. A. and M. J. E. Stemberg, Protein structure prediction on the web: a 
case study using the Phyre server. Nat Protoc, 2009. 4: p. 363-371. 
97. Yamada, K., T. Miyata, D. Tsuchiya, T. Oyama, Y. Fujiwara, T. Ohnishi, H. 
Iwasaki, H. Shinagawa, M. Ariyoshi, K. Mayanagi, and K. Morikawa, Crystal 
structure of the RuvA-RuvB complex: a structural basis for the holliday junction 
migrating motor machinery. Mol. Cell, 2002. 10: p. 671-681. 
98. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhan, W. Miller, 
and D. J. Lipman, Gapped BLAST an PSI-BLAST: a new generation of protein 







6.1. DNA sequence of aes from E. coli str. K12 substr. 
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which is the transcriptional activator of the maltose regulon.  Moreover, a recent 
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